$swkh 2023 Q1 10-K

Concept	2023 Q1	2022 Q4	2022
Revenue	$9.411M	$9.797M	$41.48M
YoY Change	-15.45%	-34.49%	-26.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.540M	$5.928M	$16.45M
YoY Change	-19.62%	56.21%	20.81%
% of Gross Profit
Research & Development	$719.0K	$1.779M	$6.952M
YoY Change	-62.18%	0.51%	-5.38%
% of Gross Profit
Depreciation & Amortization	$648.0K	$635.0K	$2.599M
YoY Change	-7.95%	-16.01%	-36.0%
% of Gross Profit
Operating Expenses	$719.0K	$8.342M	$6.952M
YoY Change	-87.53%	31.97%	-72.22%
Operating Profit
YoY Change
Interest Expense	$182.0K	-$5.834M	$340.0K
YoY Change	-122.72%	2732.04%	-81.95%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$4.526M	-$4.379M	$9.491M
YoY Change	-0.85%	-151.95%	-71.25%
Income Tax	-$109.0K	-$7.211M	-$4.000M
% Of Pretax Income	-2.41%		-42.15%
Net Earnings	$4.635M	$2.832M	$13.49M
YoY Change	33.27%	-55.24%	-47.97%
Net Earnings / Revenue	49.25%	28.91%	32.52%
Basic Earnings Per Share	$0.36		$1.05
Diluted Earnings Per Share	$0.36	$0.22	$1.05
COMMON SHARES
Basic Shares Outstanding	12.82B shares	12.82M shares	12.84M shares
Diluted Shares Outstanding	12.88M shares		12.88M shares

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.244M	$6.156M	$6.156M
YoY Change	-92.35%	-85.98%	-85.98%
Cash & Equivalents	$3.244M	$6.156M	$6.156M
Short-Term Investments			$0.00
Other Short-Term Assets	$1.287M	$1.114M	$1.114M
YoY Change	-18.34%	-35.5%	-35.5%
Inventory
Prepaid Expenses
Receivables	$4.345M	$3.094M	$3.094M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.876M	$10.36M	$10.36M
YoY Change	-80.69%	-78.15%	-78.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.627M	$5.840M	$5.840M
YoY Change	-6.08%	1.06%	1.06%
Goodwill	$8.404M	$8.404M
YoY Change		0.0%
Intangibles	$7.764M	$8.190M
YoY Change		-17.8%
Long-Term Investments	$66.00K	$76.00K	$76.00K
YoY Change	-98.17%	-97.89%	-97.89%
Other Assets	$2.401M	$1.742M	$30.19M
YoY Change	-90.1%	-11.57%	16.45%
Total Long-Term Assets	$291.9M	$289.3M	$289.3M
YoY Change	21.61%	22.96%	22.96%
TOTAL ASSETS
Total Short-Term Assets	$8.876M	$10.36M	$10.36M
Total Long-Term Assets	$291.9M	$289.3M	$289.3M
Total Assets	$300.7M	$299.6M	$299.6M
YoY Change	5.17%	6.0%	6.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.800M	$3.902M	$3.902M
YoY Change	-62.99%	-23.29%	-23.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$10.48M	$2.445M	$2.445M
YoY Change		30462.5%	30462.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.32M	$6.347M	$6.347M
YoY Change	153.24%	24.57%	24.57%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.837M	$2.145M	$13.35M
YoY Change	-72.42%	18.9%	29.14%
Total Long-Term Liabilities	$2.837M	$2.145M	$13.35M
YoY Change	-72.42%	18.9%	29.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.32M	$6.347M	$6.347M
Total Long-Term Liabilities	$2.837M	$2.145M	$13.35M
Total Liabilities	$26.35M	$19.69M	$19.69M
YoY Change	73.93%	27.63%	27.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.156B	-$4.151B
YoY Change		-0.32%
Common Stock	$12.00K	$12.00K
YoY Change		-7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$274.4M	$279.9M	$279.9M
YoY Change
Total Liabilities & Shareholders Equity	$300.7M	$299.6M	$299.6M
YoY Change	5.17%	6.0%	6.0%

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$4.635M	$2.832M	$13.49M
YoY Change	33.27%	-55.24%	-47.97%
Depreciation, Depletion And Amortization	$648.0K	$635.0K	$2.599M
YoY Change	-7.95%	-16.01%	-36.0%
Cash From Operating Activities	$664.0K	$3.095M	$8.202M
YoY Change	-84.39%	-72.42%	-76.08%
INVESTING ACTIVITIES
Capital Expenditures	$8.000K	$103.0K	$297.0K
YoY Change	-113.79%	-151.24%	-127.55%
Acquisitions
YoY Change
Other Investing Activities	-$11.07M	-$15.64M	-$43.25M
YoY Change	95.9%	-200.46%
Cash From Investing Activities	-$11.08M	-$15.74M	-$43.55M
YoY Change	94.05%	-202.44%	-269.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.138M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$7.506M	-594.0K	-$1.361M
YoY Change	-93925.0%	-74.92%	-93.26%
NET CHANGE
Cash From Operating Activities	$664.0K	3.095M	$8.202M
Cash From Investing Activities	-$11.08M	-15.74M	-$43.55M
Cash From Financing Activities	$7.506M	-594.0K	-$1.361M
Net Change In Cash	-$2.912M	-13.24M	-$36.71M
YoY Change	98.91%	-154.67%	-192.1%
FREE CASH FLOW
Cash From Operating Activities	$664.0K	$3.095M	$8.202M
Capital Expenditures	$8.000K	$103.0K	$297.0K
Free Cash Flow	$656.0K	$2.992M	$7.905M
YoY Change	-84.79%	-73.81%	-77.65%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001089907
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2021Q4	us-gaap	Derivative Instruments And Hedges DerivativeInstrumentsAndHedges		usd
CY2022Q4	us-gaap	Cost Method Investments CostMethodInvestments		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		usd
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax		usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		usd
CY2021	swkh	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability		usd
CY2021	swkh	Derivative Instrument Receivable DerivativeInstrumentReceivable		usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
CY2022	swkh	Cash Received From Settlement Of Warrants CashReceivedFromSettlementOfWarrants		usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	swkh	Fair Value Of Common Stock Received In Connection With Payoff Of Term Loan FairValueOfCommonStockReceivedInConnectionWithPayoffOfTermLoan		usd
CY2021	swkh	Fair Value Of Common Stock Received Upon Exercise Of Warrant FairValueOfCommonStockReceivedUponExerciseOfWarrant		usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2021	swkh	Effective Income Tax Rate Reconciliation Mark To Market Adjustments EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39184
CY2022	dei	Entity Registrant Name EntityRegistrantName	SWK HOLDINGS CORPORATION
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0435679
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	14755 Preston Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 105
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
CY2022	dei	City Area Code CityAreaCode	972
CY2022	dei	Local Phone Number LocalPhoneNumber	687-7250
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	SWKH
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	63839329	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12815813000	shares
CY2022	dei	Auditor Name AuditorName	BPM LLP
CY2022	dei	Auditor Firm AuditorFirmId	207
CY2022	dei	Auditor Location AuditorLocation	San Francisco, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6156000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42863000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3094000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1803000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	1034000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1114000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1727000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10364000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47427000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	236555000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	181553000	usd
CY2022Q4	us-gaap	Derivative Instruments And Hedges DerivativeInstrumentsAndHedges	2750000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	119000	usd
CY2021Q4	us-gaap	Cost Method Investments CostMethodInvestments	3491000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	24480000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	20539000	usd
CY2022Q4	swkh	Warrant Assets WarrantAssets	1220000	usd
CY2021Q4	swkh	Warrant Assets WarrantAssets	3419000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8190000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9964000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8404000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8404000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5840000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5779000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1742000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1970000	usd
CY2022Q4	us-gaap	Assets Assets	299621000	usd
CY2021Q4	us-gaap	Assets Assets	282665000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3902000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5087000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2445000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	8000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6347000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5095000	usd
CY2022Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	11200000	usd
CY2021Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	8530000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2145000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1804000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19692000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	15429000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12843157	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12843157	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12836133	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12836133	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4430922000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4431719000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4151005000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4164496000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	279929000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267236000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	299621000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	282665000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	35461000	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	39310000	usd
CY2022	swkh	Pharmaceutical Development Revenue PharmaceuticalDevelopmentRevenue	5485000	usd
CY2021	swkh	Pharmaceutical Development Revenue PharmaceuticalDevelopmentRevenue	16122000	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	538000	usd
CY2021	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	723000	usd
CY2022	us-gaap	Revenues Revenues	41484000	usd
CY2021	us-gaap	Revenues Revenues	56155000	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3491000	usd
CY2022	us-gaap	Interest Expense InterestExpense	340000	usd
CY2021	us-gaap	Interest Expense InterestExpense	374000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6952000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7347000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12964000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13620000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2021	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-287000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2599000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4061000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	-9968000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	-31040000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	417000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	272000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-528000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1839000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-151000	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-140000	usd
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	-215000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9491000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33011000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7082000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	25929000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12835000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12796000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12880000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12834000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	240512000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1163000	usd
CY2021	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-368000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	25929000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267236000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2022	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-160000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1138000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	13491000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	279929000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	25929000	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3491000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	69000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	49000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3941000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	6952000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-417000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-272000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-528000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1839000	usd
CY2022	swkh	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	754000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-151000	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-140000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2021	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-287000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2204000	usd
CY2021	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	1130000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	5995000	usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	950000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1163000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2599000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4061000	usd
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-1291000	usd
CY2021	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	108000	usd
CY2022	swkh	Derivative Instrument Receivable DerivativeInstrumentReceivable	-539000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	44000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1788000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1599000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2159000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8202000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34295000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	4151000	usd
CY2021	swkh	Cash Received From Settlement Of Warrants CashReceivedFromSettlementOfWarrants	1875000	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	93118000	usd
CY2021	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	42350000	usd
CY2022	swkh	Proceeds Repayment Of Finance Receivables ProceedsRepaymentOfFinanceReceivables	45673000	usd
CY2021	swkh	Proceeds Repayment Of Finance Receivables ProceedsRepaymentOfFinanceReceivables	67192000	usd
CY2022	swkh	Marketable Investment Principal Payment MarketableInvestmentPrincipalPayment	43000	usd
CY2021	swkh	Marketable Investment Principal Payment MarketableInvestmentPrincipalPayment	122000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	297000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1078000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43548000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25761000	usd
CY2022	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-160000	usd
CY2021	swkh	Net Settlement For Employee Taxes On Restricted Stock And Options NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions	-368000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1138000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2437000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-11750000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2500000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	8083000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1361000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20201000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36707000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39855000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42863000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3008000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6156000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42863000	usd
CY2022	swkh	Warrants Received In Conjunction With Purchase Of Financial Receivables WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables	1180000	usd
CY2021	swkh	Warrants Received In Conjunction With Purchase Of Financial Receivables WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables	175000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	268000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	110000	usd
CY2021	swkh	Fair Value Of Common Stock Received In Connection With Payoff Of Term Loan FairValueOfCommonStockReceivedInConnectionWithPayoffOfTermLoan	887000	usd
CY2022	swkh	Fair Value Of Common Stock Received Upon Exercise Of Warrant FairValueOfCommonStockReceivedUponExerciseOfWarrant	3667000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	600000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	600000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zK18xEkk8oH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_862_z5NuuorJ8rij">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are required in the determination of revenue recognition; stock-based compensation; valuation of accounts receivable; impairment of finance receivables; long-lived assets; property and equipment; intangible assets; goodwill; valuation of warrants and other investments; contingent consideration; income taxes; and contingencies and litigation, among others. Some of these judgments can be subjective and complex, and consequently, actual results may differ from these estimates. The Company’s estimates often are based on complex judgments, probabilities and assumptions that it believes to be reasonable but that are inherently uncertain and unpredictable. For any given individual estimate or assumption made by the Company, there may also be other estimates or assumptions that are reasonable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company regularly evaluates its estimates and assumptions using historical experience and other factors, including the economic environment. As future events and their effects cannot be determined with precision, the Company’s estimates and assumptions may prove to be incomplete or inaccurate, or unanticipated events and circumstances may occur that might cause changes to those estimates and assumptions. Market conditions, such as illiquid credit markets, health crises such as the COVID-19 global pandemic, volatile equity markets, and economic downturns, can increase the uncertainty already inherent in the Company’s estimates and assumptions. The Company adjusts its estimates and assumptions when facts and circumstances indicate the need for change. Those changes generally will be reflected in our consolidated financial statements on a prospective basis unless they are required to be treated retrospectively under the relevant accounting standard. It is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.</span></p>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	number
CY2022	swkh	Disclosure Swk Holdings Corporation And Summary Of Significant Accounting Policies Details Abstract DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetailsAbstract_zqTPT6iPvHo6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SWK Holdings Corporation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 39%; font-weight: bold">Asset</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 39%; font-weight: bold; text-align: left">Estimated Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left">Lesser of lease term or useful life</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture, fixtures and equipment</td><td> </td> <td style="text-align: left"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxH_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z8GPNA1TwrXg" title="::XDX::P3Y">3</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxH_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zHfwr9FadjDg" title="::XDX::P15Y">15</span> years</td></tr> </table>
CY2022	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_842_eus-gaap--RevenueRecognitionDeferredRevenue_znQcWCAGWFsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_864_zagilCQ8jZZ1">Deferred Revenue and Deferred Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Deferred revenue includes amounts that have been billed per the contractual terms but have not been recognized as revenue. The Company classifies as current the portion of deferred revenue that is expected to be recognized within one year from the balance sheet date. Deferred revenue was $33,000 and $0.2 million as of December 31, 2022 and 2021, respectively, and is included in accounts payable and accrued liabilities in the consolidated balance sheets.</span></p>
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12796000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	38000	shares
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<p id="xdx_840_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_zzgLlzkeC80g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86D_zmFy7ec42fO6">Allowance for Credit Losses on Finance Receivables</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for credit losses is intended to provide for credit losses inherent in the finance receivables portfolio and is periodically reviewed for adequacy considering credit quality indicators, including expected and historical losses and levels of and trends in past due loans, non-performing assets and impaired loans, collateral values and economic conditions. The allowance for credit losses is determined based on specific allowances for loans that are impaired, based upon the value of underlying collateral or projected cash flows. Changes to the allowance for credit losses are recorded in the provision for loan credit losses in the consolidated statements of income.</span></p>
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12880000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12834000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zkW7IKI9Y7eg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86F_zTrUlfTbgcGe">Certain Risks and Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance receivables and marketable investments. The Company invests its excess cash with major U.S. banks and financial institutions. The Company has not experienced any losses on its cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Finance Receivables Segment<span style="color: #EE2724"> </span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company performs ongoing credit evaluations of its partner companies and generally requires collateral. For the year ended December 31, 2022, two of our business partners accounted for 31 percent of our interest and accounts receivable. For the year ended December 31, 2021, five of our business partners accounted for 63 percent of our interest and accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>Pharmaceutical Development Segment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, Cara accounted for approximately 87 percent and 98 percent, respectively, of Pharmaceutical Development segment revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company does not expect its current or future credit risk exposures to have a significant impact on its operations. However, there can be no assurance that its business will not experience any adverse impact from credit risk in the future.</span></p>
CY2022	swkh	Disclosure Swk Holdings Corporation And Summary Of Significant Accounting Policies Details2 Abstract DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetails2Abstract_pn3n3_z5rbFwwCMBwh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SWK Holdings Corporation and Summary of Significant Accounting Policies (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20220101__20221231_zpb7cWme37x9" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49E_20210101__20211231_zQwNSsJX2qA8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ProfitLoss_zr1QHFN6jCj3" style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Net income</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">25,929</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pin3_zGoIVLXS7tth" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,835</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,796</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pin3_z0HKGcTLu5pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Effect of dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">38</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pin3_ztIYF6NaQ123" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Weighted-average diluted shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,880</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,834</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_pid_zMjdv5pJvsPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Basic net income per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EarningsPerShareDiluted_pid_zb7k9TyEYW27" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.65pt; padding-left: 8.65pt">Diluted net income per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	25929000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12835000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.02
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	248000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	368000	shares
CY2022	swkh	Disclosure Goodwill And Intangible Assets Details Abstract DisclosureGoodwillAndIntangibleAssetsDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureGoodwillAndIntangibleAssetsDetailsAbstract_pn3n3_zsxuJiJibrMg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; margin-bottom: 10pt" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_480_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zQ0Wa9aZrVhh" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_48C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zD3bJgDacXUc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_484_eus-gaap--IntangibleAssetsCurrent_iI_zs48BxRpwaN2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Book<br/> Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Net Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Estimated Useful<br/> Life</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_410_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zgh1zclf5Bb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"><span style="font: 10pt Times New Roman, Times, Serif">License Agreement<sup id="xdx_F46_zyHjscSe4Zy2">(1)</sup></span></td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">29,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">21,509</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">7,891</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7p5iSO7xCxl" style="width: 8%; text-align: right" title="::XDX::P10Y">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z1AUtzPHSo2i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Trade names and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">210</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z5xGdeGIGvSk" style="text-align: right" title="::XDX::P10Y">10</td><td style="text-align: left"> </td></tr> <tr id="xdx_417_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zgqNe6HwGdpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Customer relationships</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">160</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfWv7I7vp7Og" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P10Y">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_418_20221231_zRYoVEjUyR0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_480_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zbNAZvNlYdu5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_48C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zlGMWFJZq7q6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_484_eus-gaap--IntangibleAssetsCurrent_iI_zVWLMUO29IVk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Book<br/> Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Net Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Estimated Useful <br/> Life</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_41A_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zGSDTLCZv6H4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"><span style="font: 10pt Times New Roman, Times, Serif">License Agreement<sup id="xdx_F40_zHMLl2mtaaRi">(1)</sup></span></td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">29,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">19,780</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">9,620</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zoA0HCAeFn0c" style="width: 8%; text-align: right" title="::XDX::P10Y">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zu39LPIQHPnj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Trade names and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">210</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zALkzpCVJNbg" style="text-align: right" title="::XDX::P10Y">10</td><td style="text-align: left"> </td></tr> <tr id="xdx_417_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zOp9ki876L2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Customer relationships</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">56</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">184</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zzk74S8oFfC5" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P10Y">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_410_20211231_z4ZKGtk4NA3d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,886</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,964</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 12pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0F_zC5MNT8jEqT2">(1)</sup></span></td><td style="text-align: justify"><span id="xdx_F19_zwDQxw3zt3p9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to our acquisition of Enteris, Enteris entered into the License Agreement with Cara, for oral formulation rights to Enteris’ Peptelligence® technology to develop and commercialize Oral KORSUVA<sup>TM</sup> in any indication worldwide, excluding South Korea and Japan. Cara is obligated to pay Enteris certain development, regulatory and tiered commercial milestone payments, as well as low single-digit royalties based on net sales in the licensed territory.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Amortization expense was $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn3p0_dm_c20220101__20221231_zcA1fDIZL4wk">1.8 million</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3p0_dm_c20210101__20211231_zFds0dwXRFE8">3.5 million</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">for the years ended </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022 and 2021<span style="color: #212529">, respectively, and was recorded in the consolidated statements of net income. Based on amounts recorded at December 31, 2022, the Company will recognize acquired intangible asset amortization as follows (in thousands):</span></span></p> <p id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z0QmMqaUmZi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_8BC_zP2eS06DrRyf" style="display: none">Schedule of Intangible Asset Amortization Expense</span></p>
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29850000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21660000	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	8190000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29850000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19886000	usd
CY2021Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	9964000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3500000	usd
CY2022	swkh	Disclosure Goodwill And Intangible Assets Details2 Abstract DisclosureGoodwillAndIntangibleAssetsDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureGoodwillAndIntangibleAssetsDetails2Abstract_pn3n3_zjVskG2RNl6f" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"/><td/> <td style="text-align: left"/><td id="xdx_49F_20221231_zhQP5FIhkk66" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzQY9_zFXwOzEFn7J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; text-align: left">2023</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,703</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzQY9_zBVYjP8bztW2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,546</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzQY9_zNbTdJtfRPkh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzQY9_znUGkDeT5fY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANzQY9_zpVyXwft0ET" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANzQY9_zsad9mIcsKa6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,713</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzQY9_zWMEgFQdSeRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1703000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1546000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1076000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1076000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1076000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1713000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8190000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	59000	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	38000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3656000	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3648000	usd
CY2022	swkh	Disclosure Finance Receivables Details Abstract DisclosureFinanceReceivablesDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureFinanceReceivablesDetailsAbstract_pn3n3_zt1IEALN7Gjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Finance Receivables (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49C_20221231_zJ8svBVyfIFb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49E_20211231_zbjC8vMapVK8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NotesReceivableGross_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceTermLoansMember_z3eoHSZVERt8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Term loans</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">188,836</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NotesReceivableGross_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceRoyaltyPurchasesMember_z4E8tGZPQg6h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Royalty purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">59,565</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesReceivableGross_iI_maNRNzInv_zQqV5GVJD42f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Total before allowance for credit losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">248,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">189,941</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iNI_di_msNRNzInv_zgAZANXaNO2b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Allowance for credit losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,846</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(8,388</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NotesReceivableNet_iTI_mtNRNzInv_zqWGlkzF6877" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Total carrying value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">236,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	248401000	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	189941000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11846000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8388000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	236555000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	181553000	usd
CY2022	swkh	Disclosure Finance Receivables Details2 Abstract DisclosureFinanceReceivablesDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureFinanceReceivablesDetails2Abstract_pn3n3_zvGRaHcWPsVl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Finance Receivables (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_493_20221231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_zj9JdNrgCwLj" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20221231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--PerformingFinancingReceivableMember_zfFGKJRXY4Eb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49C_20221231_zuePmZ8lohn4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_492_20211231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_zebOYuJapcgc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_492_20211231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--PerformingFinancingReceivableMember_z5LnWvwVezu6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49B_20211231_zOsBFiWzFfEf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nonaccrual</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Performing</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nonaccrual</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Performing</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_405_eus-gaap--NotesReceivableNet_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceTermLoansMember_zIE7WFLmZCeh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Term loans</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">11,304</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">177,532</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">188,836</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">18,288</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">118,024</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NotesReceivableNet_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceRoyaltyPurchasesMember_zicgC1AqsBVg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Royalty purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,736</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,983</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">47,719</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,362</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,879</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,241</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesReceivableNet_iI_zB7qztMLf9mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Total carrying value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,040</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">218,515</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">236,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">159,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	236555000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	181553000	usd
CY2022	swkh	Disclosure Property And Equipment Net Details Abstract DisclosurePropertyAndEquipmentNetDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--DisclosurePropertyAndEquipmentNetDetailsAbstract_pn3n3_zdbaG44OmPn1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20221231_zUX5aNhX3Zu1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20211231_zuw8RLh7Anj8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentOther_iI_maPPAEGzBKP_zZTpZvwvr368" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Production equipment and other</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,895</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FurnitureAndFixturesGross_iI_maPPAEGzBKP_zzroXv0an7Kb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LeaseholdImprovementsGross_iI_maPPAEGzBKP_zuzdqUqGN4Tj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,648</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CapitalizedComputerSoftwareGross_iI_maPPAEGzBKP_z1pTI4UoFFg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Capitalized software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">87</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">84</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iTI_mtPPAEGzBKP_maPPAENzbIj_z8J1Mme4cSU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,697</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,812</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbIj_zZdQlv2YqyAa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,857</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,033</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbIj_zLXCZyDASc12" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,840</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,779</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	3895000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	3042000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	87000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	84000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7697000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6812000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1857000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1033000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5840000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5779000	usd
CY2022	swkh	Disclosure Marketable Investments Details Abstract DisclosureMarketableInvestmentsDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureMarketableInvestmentsDetailsAbstract_pn3n3_zd0KPodjOYZf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_499_20221231_zxdEgvXpuylk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49F_20211231_zdN5shFp05u5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year Ended <br/>December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_maIzegN_zKQnm1NRipAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Corporate debt securities</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">119</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MarketableSecurities_iI_maIzegN_zRoEpU1rXEq4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Equity securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0677">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,034</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Investments_iTI_mtIzegN_zaN5aJhHICW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total marketable investments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,153</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	76000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	119000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	1034000	usd
CY2022Q4	us-gaap	Investments Investments	76000	usd
CY2021Q4	us-gaap	Investments Investments	1153000	usd
CY2022	swkh	Disclosure Marketable Investments Details2 Abstract DisclosureMarketableInvestmentsDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureMarketableInvestmentsDetails2Abstract_pn3n3_zuTRgxo1KBag" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Amortized Cost</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Unrealized<br/> Gains</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Unrealized<br/> Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2022</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zaxmlAK9Hkkk" style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zV6a7JKgMXrd" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0687">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zz5GakUq3ZG1" style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AvailableForSaleSecurities_iI_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zmAkQa3xSN64" style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zSoAzFDQvf7i" style="text-align: right">119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zI1gGuSsJiei" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_c20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_z1Muzy8WZIFi" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0692">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecurities_iI_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zHLX646asxQ8" style="text-align: right">119</td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Marketable Investments Details3 Abstract DisclosureMarketableInvestmentsDetails3Abstract	<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureMarketableInvestmentsDetails3Abstract_pn3n3_zM0Wu76HhGF4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_498_20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zVSLCsr5JEkk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49A_20210101__20211231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zUFmsUS4JBb3" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_z42jp1xjUUL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Unrealized net (loss) gain on equity securities reflected in the Consolidated Statements of Income</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(528</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,839</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfCommonStockReceivedUponExerciseOfWarrant_zW6xKOWQdqE4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Fair value of common stock received upon exercise of warrant to purchase stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--CashReceivedFromSettlementOfWarrants_zVbLRU47Yh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Proceeds received on sale/tender of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,875</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--MarketableSecuritiesGainLoss_zOQAbGedznti" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Realized net loss on sale/tender of equity securities reflected in the Consolidated Statements of Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(151</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(140</td><td style="text-align: left">)</td></tr> </table>
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	2400000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	32600000	usd
CY2022	swkh	Disclosure Commitments And Contingencies Details Abstract DisclosureCommitmentsAndContingenciesDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureCommitmentsAndContingenciesDetailsAbstract_pn3n3_zpU8FXZFppGi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"/><td/> <td style="text-align: left"/><td id="xdx_490_20221231_zzAedsHjg849" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbLh_zLWry4gWXXzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2023</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">335</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbLh_z0yCi6YHWdod" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbLh_zY5ZnWnT9Tdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbLh_zlB5UuO9emB9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbLh_zrNspe3ml2Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbLh_zzkPZN6uWoyd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-align: left; text-indent: -8.65pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">549</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbLh_zt4cpzHqKkg3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total future lease payments</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,099</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	335000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	336000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	325000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	277000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	277000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	549000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2099000	usd
CY2021Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	3419000	usd
CY2021Q4	swkh	Contingent Consideration Payable At Fair Value ContingentConsiderationPayableAtFairValue	8530000	usd
CY2021Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	8530000	usd
CY2022	swkh	Disclosure Commitments And Contingencies Details2 Abstract DisclosureCommitmentsAndContingenciesDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureCommitmentsAndContingenciesDetails2Abstract_pn3n6_z53fljfS5eLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"/><td/> <td style="text-align: left"/><td id="xdx_485_eus-gaap--CommitmentsAndContingencies_iI_pn3n6_zVb4rGJD84i7" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_41E_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ExeevoIncMember_zKvxgda1jkS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Exeevo, Inc.</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2.5</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_419_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MedMinderSystemsIncMember_zPeuxVFfxuc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">MedMinder Systems, Inc.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.0</td><td style="text-align: left"> </td></tr> <tr id="xdx_419_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DuoRoyaltyMember_znI43rpc5QAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Duo Royalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.4</td><td style="text-align: left"> </td></tr> <tr id="xdx_41A_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SincerusPharmaceuticalsIncMember_zsX61P64P8w8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Sincerus Pharmaceuticals, Inc.</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2.0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_41A_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember_zD5USy1GWoV7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total unfunded commitments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000.0	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	63901	shares
CY2022	swkh	Disclosure Stockholders Equity Details Abstract DisclosureStockholdersEquityDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--DisclosureStockholdersEquityDetailsAbstract_pp0p0_zCyv6jvkabsi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number of<br/> Shares</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-<br/> Average Exercise<br/> Price</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Term <br/> (in years)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Aggregate <br/> Intrinsic Value <br/> (in thousands)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2020</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVkIjHrUVoM2" style="width: 8%; text-align: right">362,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3c3QbpjliRe" style="width: 8%; text-align: right">12.47</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshs1LJRrIWd" style="width: 8%; text-align: right" title="::XDX::P5Y7M6D">5.6</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0n3_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW4P4u6t3sJ6" style="width: 8%; text-align: right">810.1</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options canceled and retired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkjxaQRqDNs6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDmKKkgoMpsh" style="text-align: right">(75,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDccnebvD5m4" style="text-align: right">8.30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Options granted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlVeVpuUczn1" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU9S3ngfS9dl" style="text-align: right">287,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za7VU7uE5b4c" style="text-align: right">10.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlKYbtq5IHuh" style="text-align: right" title="::XDX::P5Y8M12D">5.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0n3_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZGuO6ned5ei" style="text-align: right">1745.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options canceled and retired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt7l0vpbUnZa" style="text-align: right">(72,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEj8ZXezlVc3" style="text-align: right">14.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVxNlwszPOmi" style="text-align: right">(125,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTNplNmismjd" style="text-align: right">12.98</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Options granted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z45VifDwBEa6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3WJlOFVFqj" style="border-bottom: Black 2.5pt double; text-align: right">90,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwRfoRanQga1" style="padding-bottom: 2.5pt; text-align: right">10.88</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhX5i86I0xTl" style="padding-bottom: 2.5pt; text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0n3_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVHQKNehgCR6" style="padding-bottom: 2.5pt; text-align: right">363.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Options vested and exercisable and expected to be vested and exercisable at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcmd9fwMuL9k" style="text-align: right">90,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za5wq1wOmQFa" style="text-align: right">10.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVmQdxaUe1zi" style="text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0n3_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqUIrq4xRQrl" style="text-align: right">363.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Options vested and exercisable at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvAdD4fF6Px" style="text-align: right">82,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKwyDpYLIFWf" style="text-align: right">13.35</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z12gak5G2amk" style="text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0n3_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zarezMQXTCe2" style="text-align: right">353.7</td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Stockholders Equity Details2 Abstract DisclosureStockholdersEquityDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureStockholdersEquityDetails2Abstract_pid_zh6tYX6N5AYa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Stockholders' Equity (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Exercise Prices</b></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_484_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_zjVsK018QVdd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number<br/> Outstanding</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining <br/> Contractual Life <br/> (in years)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_486_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_zYgUQVEgyHMa" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-<br/> Average Exercise <br/> Price per Share</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_481_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_zgBKJRwQfkPc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number<br/> Exercisable</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_480_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_z556Y2AvTgzl" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-<br/> Average Exercise <br/> Price per Share</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_412_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.61Member_zYjUtxnWhls5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">9.61</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.61Member_z3oXFie4HJEe" style="width: 13%; text-align: right" title="::XDX::P0Y">3.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9.61</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9.61</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_41D_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50Member_zAtXg2Da7g94" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">12.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxHU_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50Member_ztTEDtHlLwdd" style="text-align: right" title="::XDX::P0Y">6.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td></tr> <tr id="xdx_410_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50TwoMember_zWn21S0JuSTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">12.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxHU_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50TwoMember_z1fOS3Ybbp9e" style="text-align: right" title="::XDX::P0Y">6.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29Member_z0i8UnOXjAMb" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29Member_z716Idot1FTg" style="text-align: right" title="::XDX::P0Y">7.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29TwoMember_zl4323qygeD" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29TwoMember_zwzMVEgx3XLg" style="text-align: right" title="::XDX::P0Y">7.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td></tr> <tr id="xdx_41E_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29ThreeMember_zQA7y92LYa1b" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29ThreeMember_zwpils8MthQk" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P0Y">7.5</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16.29</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16.29</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_410_20221231_zCdZk3BinOEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="padding-left: 8.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">90,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10.88</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">82,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13.35</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	90000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.88
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	82500	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	13.35
CY2022	swkh	Disclosure Fair Value Measurements Details Abstract DisclosureFairValueMeasurementsDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureFairValueMeasurementsDetailsAbstract_pn3n3_zCtNjup7cPxk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztB4SbiPksbe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying<br/> Value in <br/> Consolidated<br/> Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqMxfOx5jMPe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in <br/> Active Markets for<br/> Identical Assets or<br/> Liabilities <br/>(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSnlMjZ2unKf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other<br/> Observable Inputs <br/>(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgJPJTuT2d9e" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs <br/>(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_ecustom--FinancialAssetsAbstract_iB_zBWnTRuTUilf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--WarrantAssets_i01I_pn3n3_z2llb6lxIJQk" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0847">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,220</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InvestmentsFairValueDisclosure_i01I_pn3n3_zOy9vpdXWse6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0853">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--FinancialLiabilitiesAbstract_iB_zZNWr2vofZwb" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--ContingentConsiderationPayable_i01I_pn3n3_z5luIMp6qtMh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DerivativeLiabilities_i01I_pn3n3_zIMseKoQO1hk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Derivative liability - foreign currency forward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0867">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0868">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The following table presents financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 (in thousands):</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzM1bxPLiWu9" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying<br/> Value in<br/> Consolidated <br/> Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zEhhC0CULux6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in<br/> Active Markets for<br/> Identical Assets or<br/> Liabilities <br/>(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRHzf8RULGj8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other<br/> Observable Inputs <br/>(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGkZ1478Ag5i" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant <br/> Unobservable<br/> Inputs <br/>(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--FinancialAssetsAbstract_iB_zraJcVtpCUUe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--WarrantAssets_i01I_pn3n3_zrrDHF3L2yXc" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,419</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0877">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0878">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,419</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InvestmentsFairValueDisclosure_i01I_pn3n3_zuiOsTPX9O5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0883">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--FinancialLiabilitiesAbstract_iB_zwHJUFK4fqBg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ContingentConsiderationPayable_i01I_pn3n3_zGiyoeUIRwEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0892">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0893">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Fair Value Measurements Details2 Abstract DisclosureFairValueMeasurementsDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureFairValueMeasurementsDetails2Abstract_pn3n3_zYks6e9Z4nEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Fair Value Measurements (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B9_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsRecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_zUZMheTE7bel" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_438_c20210101__20211231_ecustom--WarrantAssets_iS_pn3n3_ztQxuwewFMq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2020</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--WarrantIssuances_pn3n3_zEZkRiVDGo4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175</td><td style="text-align: left"> </td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--WarrantsCanceled_pn3n3_zuIimkJglXhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0904">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_433_c20210101__20211231_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_zyKlDROCbPt3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">272</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--WarrantAssets_iE_pn3n3_zAiqhKzxi732" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_430_c20220101__20221231_ecustom--WarrantIssuances_pn3n3_zoEU1lED9jEi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,180</td><td style="text-align: left"> </td></tr> <tr id="xdx_43D_c20220101__20221231_ecustom--WarrantExercised_pn3n3_zVMs6gS7i9F1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,796</td><td style="text-align: left">)</td></tr> <tr id="xdx_437_c20220101__20221231_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_znXvQ4pBtWi9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">417</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43A_c20220101__20221231_ecustom--WarrantAssets_iE_pn3n3_zMzdZ6UcE0o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,220</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Fair Value Measurements Details3 Abstract DisclosureFairValueMeasurementsDetails3Abstract	<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureFairValueMeasurementsDetails3Abstract_zQ9ioEW7BCD" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Fair Value Measurements (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Dividend rate</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 8%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp0_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zRVwXmWpLzj5">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 8%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp0_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zqnHi9CTZcjj">—</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zby83oDEDuzb">4.0%</span> to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zg8pxcxsMcNd">4.3%</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zhd0FtNEBgJl">0.97%</span> to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zyVyk38nYcO9">1.44%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Expected life (years)</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z2dMb9IZ52gc" title="::XDX::P2Y">2.0</span> to <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z1fRPYHHBpEe" title="::XDX::P6Y10M24D">6.9</span> </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_ztfivnXJUZn6" title="::XDX::P2Y7M6D">2.6</span> to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zKRiP9POL8m2" title="::XDX::P7Y">7.0</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zp7kKzjG9jWd">54.8%</span> to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zPFaFOOtDrMl">139.4%</span> </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zC5Fzp1eAukc">60.2%</span> to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zn23os7lcVK">142.0%</span></span></td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Fair Value Measurements Details4 Abstract DisclosureFairValueMeasurementsDetails4Abstract	<table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureFairValueMeasurementsDetails4Abstract_pn3n3_zwQB0veJcBfd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 4)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4BD_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_zCqQrbTpYzoe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying <br/> Value in <br/> Consolidated<br/> Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4B7_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel1Member_zI62mQ7PqFbi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in <br/> Active Markets for<br/> Identical Assets or<br/> Liabilities<br/>(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4B7_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel2Member_zqFiwtDIgLg8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other <br/> Observable Inputs <br/>(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4BE_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_zQohLh2AmH6d" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant <br/> Unobservable<br/> Inputs <br/>(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_43F_c20221231_eus-gaap--InvestmentsFairValueDisclosure_iI_z1XzxA4k4Wfh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2022</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,545</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0942">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,545</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43D_c20211231_eus-gaap--InvestmentsFairValueDisclosure_iI_z7G4zoVzTcHf" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,612</td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Fair Value Measurements Details5 Abstract DisclosureFairValueMeasurementsDetails5Abstract	<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureFairValueMeasurementsDetails5Abstract_pn3n3_zcLtqQQ4f0e7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 5)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Carrying <br/> Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20221231_zPeuca5YNePf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpgiSWUck4ib" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 1</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCwEb6NpuQH7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 2</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmbMofVqAFn1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 3</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_ecustom--FinancialAssetsAbstract0_iB_ztnjhBICpGie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LoansReceivableFairValueDisclosure_i01I_zoygMvg21XAc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance receivables</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesReceivableNet_i01I_c20221231_z4wR2g1Zb6tg" style="text-align: right">236,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">236,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">236,555</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zwJdR8AULtO2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Investments_i01I_c20221231_zBPKeSeF5uOa" style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAssetsFairValueDisclosure_i01I_zBt0Y10yTpEe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OtherAssets_i01I_c20221231_zQDwAtZ3Rtfd" style="text-align: right">1,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--FinancialLiabilitiesAbstract_iB_ziBTEYii9bMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ContingentConsiderationPayable_i01I_zErcvILvcvH5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ContingentConsiderationPayableAtFairValue_i01I_c20221231_zm7RMeyYcBT9" style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0983">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Derivative liability - foreign currency forward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td style="text-align: left"> </td><td style="text-align: left"> </td><td style="text-align: right">754</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 10pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For the year ended December 31, 2021 (in thousands):</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Carrying <br/> Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231_zkwJR7IEJ717" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zh0lKWSO04D4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 1</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIvEndzdbx1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 2</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z71KZbqVsdza" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 3</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_ecustom--FinancialAssetsAbstract0_iB_zPXCIT1QU04d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LoansReceivableFairValueDisclosure_i01I_z09Xj8E4FmLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance receivables</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesReceivableNet_i01I_c20211231_zobrWlukULbl" style="text-align: right">181,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">181,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0994">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">181,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InvestmentsFairValueDisclosure_i01I_zJMLdYzRDMC2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Investments_i01I_c20211231_zc0fHyiYatgj" style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1001">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAssetsFairValueDisclosure_i01I_zIYt84KKLFU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherAssets_i01I_c20211231_zGMWjcBUpIG2" style="text-align: right">3,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1007">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FinancialLiabilitiesAbstract_iB_zmE60YGKClJj" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ContingentConsiderationPayable_i01I_zRF4eKRzdVz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--ContingentConsiderationPayableAtFairValue_i01I_c20211231_zjvk2kHjRZP" style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1017">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1018">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	236555000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	236555000	usd
CY2022Q4	us-gaap	Investments Investments	76000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	76000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1220000	usd
CY2022Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	1220000	usd
CY2022Q4	swkh	Contingent Consideration Payable At Fair Value ContingentConsiderationPayableAtFairValue	11200000	usd
CY2022Q4	swkh	Contingent Consideration Payable ContingentConsiderationPayable	11200000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	181553000	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	181553000	usd
CY2021Q4	us-gaap	Investments Investments	1153000	usd
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1153000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	3419000	usd
CY2022	swkh	Disclosure Revenue Recognition Details Abstract DisclosureRevenueRecognitionDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureRevenueRecognitionDetailsAbstract_pn3n3_z4wYh4pf8Em7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Revenue Recognition (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20220101__20221231_z0Um12tAl6i4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_496_20210101__20211231_zeG83YRptDqi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical Development Segment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zzo12CevErz1" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">License Agreement</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">5,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">15,871</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGUFJn8hQm0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical development and other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">753</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">974</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zi6LwJMpFCCb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total contract revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,008</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	swkh	Disclosure Revenue Recognition Details2 Abstract DisclosureRevenueRecognitionDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureRevenueRecognitionDetails2Abstract_pn3n3_zxceV6hTLrqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Revenue Recognition (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20221231_zVS4TD8XBGNg" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20211231_z2Vh0e6xWQob" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical Development Segment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredRevenue_iI_z2mjdkzRgQEi" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred revenue</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">33</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">185</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iI_zIqYUoofewch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total contract liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">33</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	33000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	185000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	33000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	185000	usd
CY2022	swkh	Disclosure Segment Information Details Abstract DisclosureSegmentInformationDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureSegmentInformationDetailsAbstract_pn3n3_znSCiOWDpFJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Year Ended December 31, 2022</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--FinanceReceivablesMember_zIEfp8G0YJve" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Finance<br/> Receivables</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zbnBurbzNDMk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Pharmaceutical<br/> Development<br/> and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--HoldingCompanyAndOtherMember_zDL3mUipRoAb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Holding<br/> Company and<br/> Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231_z8sRNDCo3vm" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_ecustom--RevenuesExcludingOtherRevenue_zPkGUsSV2Et7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">35,461</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">5,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1056">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">40,946</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueNotFromContractWithCustomerOther_zmdJFgAozWw4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">538</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ProvisionForLoanAndLeaseLosses_zCBwwjv6drG3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Provision for credit losses and impairment expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1065">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1066">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,491</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InterestExpense_z4y5UTz2CNwl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1070">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_zWOLkpVCb6gh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Manufacturing, research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1074">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,952</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,952</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ChangeInFairValueOfAcquisitionrelatedContingentConsideration_zSl0HCCp0HGl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value of contingent consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,170</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1081">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DepreciationAndAmortization_zQjwdXljuG38" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Depreciation and amortization expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,593</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GeneralAndAdministrativeExpense_z90gZphw2PRk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">333</td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,964</td><td style="text-align: left"/></tr> <tr id="xdx_406_eus-gaap--OtherOperatingIncomeExpenseNet_zHtJ894SL1Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(477</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">—</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(477</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ProfitLoss_znvlvsUklUm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Consolidated net income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,829</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,324</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,014</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,491</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Year Ended December 31, 2021</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--FinanceReceivablesMember_zMpOv2d7ZeTi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Finance<br/> Receivables</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zlB7qU3VFIJe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Pharmaceutical <br/> Development <br/> and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--HoldingCompanyAndOtherMember_zw2T9BHODmGc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Holding<br/> Company and<br/> Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231_z8p3qvInHlhd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenuesExcludingOtherRevenue_zSoVSvPgON11" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">39,310</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">16,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1106">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">55,432</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomerOther_zECjCl5rGuPg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1109">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">723</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1111">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">723</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestExpense_zchkFg520oGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1116">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ResearchAndDevelopmentExpense_z7k6yiZN07U3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Manufacturing, research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1121">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DepreciationAndAmortization_zcEjd7VsEU2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Depreciation and amortization expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1124">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,061</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ChangeInFairValueOfAcquisitionrelatedContingentConsideration_zZzhUO3JT31k" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value of acquisition-related contingent consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1129">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(287</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1131">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(287</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_zdkjzSyVPg24" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,983</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,620</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherOperatingIncomeExpenseNet_zf05rUNBZtR8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other income, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1141">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,971</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_zvHoCxSENMA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Income tax expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1144">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1145">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,082</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,082</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProfitLoss_zz4lnSa94Rtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Consolidated net income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,747</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,912</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,929</td><td style="text-align: left"> </td></tr> </table>
CY2022	swkh	Revenues Excluding Other Revenue RevenuesExcludingOtherRevenue	40946000	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	538000	usd
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3491000	usd
CY2022	us-gaap	Interest Expense InterestExpense	340000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6952000	usd
CY2022	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	5170000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2599000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12964000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-477000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	13491000	usd
CY2021	swkh	Revenues Excluding Other Revenue RevenuesExcludingOtherRevenue	55432000	usd
CY2021	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	723000	usd
CY2021	us-gaap	Interest Expense InterestExpense	374000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7347000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4061000	usd
CY2021	swkh	Change In Fair Value Of Acquisitionrelated Contingent Consideration ChangeInFairValueOfAcquisitionrelatedContingentConsideration	-287000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13620000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1971000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7082000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	25929000	usd
CY2022	swkh	Disclosure Income Taxes Details Abstract DisclosureIncomeTaxesDetailsAbstract	<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureIncomeTaxesDetailsAbstract_pn3n3_zEfWp2Udm1Kc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_498_20220101__20221231_z00BHFah80g7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49D_20210101__20211231_z72QzFO36Lyh" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--CurrentFederalTaxExpenseBenefit_zzUE9GJIJkKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-left: 8.65pt; text-indent: -8.65pt">U.S.</td><td style="width: 3%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 8%; text-align: right">9,491 </td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 8%; text-align: right">33,011</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9491000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	33011000	usd
CY2022	swkh	Disclosure Income Taxes Details2 Abstract DisclosureIncomeTaxesDetails2Abstract	<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureIncomeTaxesDetails2Abstract_pn3n3_zKlophLcNqEi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20220101__20221231_zl2DXy1jhbqd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20210101__20211231_za6HusxVFkF6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zfGQxdA0kgth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Current (benefit) expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBzrLC_zM4zhunXAs5a" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; padding-left: 17.3pt; text-indent: -8.65pt">State</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(59</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">185</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zjuG229z78oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred (benefit) expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_maITEBzrLC_zybTNOMCVHCa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Federal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,922</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,944</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBzrLC_zMQkUrQJufvk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">State</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(19</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(47</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_i01T_mtITEBzrLC_zHhTBvMgRGl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 25.95pt">Total income tax (benefit) expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-59000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	185000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3922000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6944000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-19000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-47000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7082000	usd
CY2022	swkh	Disclosure Income Taxes Details3 Abstract DisclosureIncomeTaxesDetails3Abstract	<table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureIncomeTaxesDetails3Abstract_pn3n3_z5CQgY5rLLj3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_499_20220101__20221231_zt5UpL9L4yM1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20210101__20211231_zZg4IJwyDFzc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCzIX3_ziJ1asdl3GE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Federal tax provision at statutory rate</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,035</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">6,945</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCzIX3_zlEle9KXzqr6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,587</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,208</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maCzIX3_zqnVNQiUeDi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">State taxes, net of federal income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(97</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Mark-to-market adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(88</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(58</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments_maCzIX3_zUtX1ya7zsug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Tax credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1199">—</span></td><td style="text-align: left"/></tr> <tr id="xdx_40A_ecustom--EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation_maCzIX3_zzcnuSgeWs38" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration revaluation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maCzIX3_zJ12m8tb1fba" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(125</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets_maCzIX3_zVci3RElVtn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Write off of deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,905</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,493</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_mtCzIX3_zElrtoNnjFik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total income tax (benefit) expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2035000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	6945000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-9587000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-21208000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-97000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	95000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Mark To Market Adjustments EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments	-403000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation	1044000	usd
CY2021	swkh	Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation	-60000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	191000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-125000	usd
CY2022	swkh	Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets	2905000	usd
CY2021	swkh	Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets	21493000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7082000	usd
CY2022	swkh	Disclosure Income Taxes Details4 Abstract DisclosureIncomeTaxesDetails4Abstract	<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureIncomeTaxesDetails4Abstract_pn3n3_zcd3PgBwVvyh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 4)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20221231_zgx8USZSWOpc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49D_20211231_zPzB4e4sW8Bl" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB_z49qqf2uWNAj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_maCz7ni_zUcr2S79c0yf" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Credit carryforward</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,947</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_maCz7ni_zeXZud1Kh1Ak" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_maCz7ni_zctnTA2yJ9ki" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,846</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,334</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_maCz7ni_ztFhnlkCa8Eg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Net operating losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26,158</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,362</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_mtCz7ni_maCzIIP_z6ZcS9ZX6gOd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zadp1BSkJx3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_di_msCzIIP_zMtpUwMrqQI2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Intangible assets other than goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,288</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,609</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesOther_i01I_msCzIIP_z9QadwIRHXI9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(629</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(479</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msCzIIP_zjrxQck3PUmi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,697</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,284</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtCzIIP_zaAUhILpHrre" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Net deferred tax assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,480</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">20,539</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2947000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3077000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	143000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	138000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3846000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3334000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26158000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32362000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33094000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38911000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1288000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1609000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-629000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-479000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6697000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16284000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	24480000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20539000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	124500000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	usd

CY2022

dei

Entity Central Index Key

EntityCentralIndexKey

0001089907

CY2022

dei

Amendment Flag

AmendmentFlag

false

CY2022

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2022

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2022

CY2022

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2022Q4

us-gaap

Marketable Securities

MarketableSecurities

usd

CY2021Q4

us-gaap

Derivative Instruments And Hedges

DerivativeInstrumentsAndHedges

usd

CY2022Q4

us-gaap

Cost Method Investments

CostMethodInvestments

usd

CY2021Q4

us-gaap

Preferred Stock Value

PreferredStockValue

usd

CY2021

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

usd

CY2021

us-gaap

Foreign Currency Transaction Loss Before Tax

ForeignCurrencyTransactionLossBeforeTax

usd

CY2021

us-gaap

Stock Issued During Period Value New Issues

StockIssuedDuringPeriodValueNewIssues

usd

CY2022

us-gaap

Stock Issued During Period Value New Issues

StockIssuedDuringPeriodValueNewIssues

usd

CY2021

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

usd

CY2021

swkh

Change In Fair Value Of Derivative Liability

ChangeInFairValueOfDerivativeLiability

usd

CY2021

swkh

Derivative Instrument Receivable

DerivativeInstrumentReceivable

usd

CY2021

us-gaap

Proceeds From Sale Of Equity Method Investments

ProceedsFromSaleOfEquityMethodInvestments

usd

CY2022

swkh

Cash Received From Settlement Of Warrants

CashReceivedFromSettlementOfWarrants

usd

CY2021

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

usd

CY2022

swkh

Fair Value Of Common Stock Received In Connection With Payoff Of Term Loan

FairValueOfCommonStockReceivedInConnectionWithPayoffOfTermLoan

usd

CY2021

swkh

Fair Value Of Common Stock Received Upon Exercise Of Warrant

FairValueOfCommonStockReceivedUponExerciseOfWarrant

usd

CY2022Q4

us-gaap

Marketable Securities

MarketableSecurities

usd

CY2021

swkh

Effective Income Tax Rate Reconciliation Mark To Market Adjustments

EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments

usd

CY2022

dei

Document Type

DocumentType

10-K

CY2022

dei

Document Annual Report

DocumentAnnualReport

true

CY2022

dei

Document Period End Date

DocumentPeriodEndDate

2022-12-31

CY2022

dei

Document Transition Report

DocumentTransitionReport

false

CY2022

dei

Entity File Number

EntityFileNumber

001-39184

CY2022

dei

Entity Registrant Name

EntityRegistrantName

SWK HOLDINGS CORPORATION

CY2022

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2022

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

77-0435679

CY2022

dei

Entity Address Address Line1

EntityAddressAddressLine1

14755 Preston Road

CY2022

dei

Entity Address Address Line2

EntityAddressAddressLine2

Suite 105

CY2022

dei

Entity Address City Or Town

EntityAddressCityOrTown

Dallas

CY2022

dei

Entity Address State Or Province

EntityAddressStateOrProvince

TX

CY2022

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

75254

CY2022

dei

City Area Code

CityAreaCode

972

CY2022

dei

Local Phone Number

LocalPhoneNumber

687-7250

CY2022

dei

Security12b Title

Security12bTitle

Common Stock, par value $0.001 per share

CY2022

dei

Trading Symbol

TradingSymbol

SWKH

CY2022

dei

Security Exchange Name

SecurityExchangeName

NASDAQ

CY2022

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2022

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2022

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2022

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2022

dei

Entity Filer Category

EntityFilerCategory

Non-accelerated Filer

CY2022

dei

Entity Small Business

EntitySmallBusiness

true

CY2022

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2022

dei

Entity Shell Company

EntityShellCompany

false

CY2022Q2

dei

Entity Public Float

EntityPublicFloat

63839329

usd

CY2023Q1

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

12815813000

shares

CY2022

dei

Auditor Name

AuditorName

BPM LLP

CY2022

dei

Auditor Firm

AuditorFirmId

207

CY2022

dei

Auditor Location

AuditorLocation

San Francisco, California

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

6156000

usd

CY2021Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

42863000

usd

CY2022Q4

us-gaap

Accounts Receivable Net

AccountsReceivableNet

3094000

usd

CY2021Q4

us-gaap

Accounts Receivable Net

AccountsReceivableNet

1803000

usd

CY2021Q4

us-gaap

Marketable Securities

MarketableSecurities

1034000

usd

CY2022Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

1114000

usd

CY2021Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

1727000

usd

CY2022Q4

us-gaap

Assets Current

AssetsCurrent

10364000

usd

CY2021Q4

us-gaap

Assets Current

AssetsCurrent

47427000

usd

CY2022Q4

us-gaap

Notes And Loans Receivable Net Current

NotesAndLoansReceivableNetCurrent

236555000

usd

CY2021Q4

us-gaap

Notes And Loans Receivable Net Current

NotesAndLoansReceivableNetCurrent

181553000

usd

CY2022Q4

us-gaap

Derivative Instruments And Hedges

DerivativeInstrumentsAndHedges

2750000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

76000

usd

CY2021Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

119000

usd

CY2021Q4

us-gaap

Cost Method Investments

CostMethodInvestments

3491000

usd

CY2022Q4

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

24480000

usd

CY2021Q4

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

20539000

usd

CY2022Q4

swkh

Warrant Assets

WarrantAssets

1220000

usd

CY2021Q4

swkh

Warrant Assets

WarrantAssets

3419000

usd

CY2022Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

8190000

usd

CY2021Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

9964000

usd

CY2022Q4

us-gaap

Goodwill

8404000

usd

CY2021Q4

us-gaap

Goodwill

8404000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

5840000

usd

CY2021Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

5779000

usd

CY2022Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

1742000

usd

CY2021Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

1970000

usd

CY2022Q4

us-gaap

Assets

299621000

usd

CY2021Q4

us-gaap

Assets

282665000

usd

CY2022Q4

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

3902000

usd

CY2021Q4

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

5087000

usd

CY2022Q4

us-gaap

Lines Of Credit Current

LinesOfCreditCurrent

2445000

usd

CY2021Q4

us-gaap

Lines Of Credit Current

LinesOfCreditCurrent

8000

usd

CY2022Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

6347000

usd

CY2021Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

5095000

usd

CY2022Q4

swkh

Contingent Consideration Payable

ContingentConsiderationPayable

11200000

usd

CY2021Q4

swkh

Contingent Consideration Payable

ContingentConsiderationPayable

8530000

usd

CY2022Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

2145000

usd

CY2021Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

1804000

usd

CY2022Q4

us-gaap

Liabilities

19692000

usd

CY2021Q4

us-gaap

Liabilities

15429000

usd

CY2022Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.001

CY2021Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.001

CY2022Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

5000000

shares

CY2021Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

5000000

shares

CY2022Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

0

shares

CY2022Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

shares

CY2021Q4

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

0

shares

CY2021Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

shares

CY2022Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2021Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

250000000

shares

CY2021Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

250000000

shares

CY2022Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

12843157

shares

CY2022Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

12843157

shares

CY2021Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

12836133

shares

CY2021Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

12836133

shares

CY2022Q4

us-gaap

Common Stock Value

CommonStockValue

12000

usd

CY2021Q4

us-gaap

Common Stock Value

CommonStockValue

13000

usd

CY2022Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

4430922000

usd

CY2021Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

4431719000

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-4151005000

usd

CY2021Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-4164496000

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

279929000

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

267236000

usd

CY2022Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

299621000

usd

CY2021Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

282665000

usd

CY2022

us-gaap

Interest And Fee Income Loans And Leases

InterestAndFeeIncomeLoansAndLeases

35461000

usd

CY2021

us-gaap

Interest And Fee Income Loans And Leases

InterestAndFeeIncomeLoansAndLeases

39310000

usd

CY2022

swkh

Pharmaceutical Development Revenue

PharmaceuticalDevelopmentRevenue

5485000

usd

CY2021

swkh

Pharmaceutical Development Revenue

PharmaceuticalDevelopmentRevenue

16122000

usd

CY2022

us-gaap

Revenue Not From Contract With Customer Other

RevenueNotFromContractWithCustomerOther

538000

usd

CY2021

us-gaap

Revenue Not From Contract With Customer Other

RevenueNotFromContractWithCustomerOther

723000

usd

CY2022

us-gaap

Revenues

41484000

usd

CY2021

us-gaap

Revenues

56155000

usd

CY2022

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

3491000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

340000

usd

CY2021

us-gaap

Interest Expense

InterestExpense

374000

usd

CY2022

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

6952000

usd

CY2021

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

7347000

usd

CY2022

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

12964000

usd

CY2021

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

13620000

usd

CY2022

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

5170000

usd

CY2021

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

-287000

usd

CY2022

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

2599000

usd

CY2021

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

4061000

usd

CY2022

us-gaap

Costs And Expenses

CostsAndExpenses

-9968000

usd

CY2021

us-gaap

Costs And Expenses

CostsAndExpenses

-31040000

usd

CY2022

us-gaap

Unrealized Gain Loss On Derivatives

UnrealizedGainLossOnDerivatives

417000

usd

CY2021

us-gaap

Unrealized Gain Loss On Derivatives

UnrealizedGainLossOnDerivatives

272000

usd

CY2022

us-gaap

Marketable Securities Unrealized Gain Loss

MarketableSecuritiesUnrealizedGainLoss

-528000

usd

CY2021

us-gaap

Marketable Securities Unrealized Gain Loss

MarketableSecuritiesUnrealizedGainLoss

1839000

usd

CY2022

us-gaap

Marketable Securities Gain Loss

MarketableSecuritiesGainLoss

-151000

usd

CY2021

us-gaap

Marketable Securities Gain Loss

MarketableSecuritiesGainLoss

-140000

usd

CY2022

us-gaap

Foreign Currency Transaction Loss Before Tax

ForeignCurrencyTransactionLossBeforeTax

-215000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments

IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

9491000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments

IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

33011000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-4000000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

7082000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

13491000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

25929000

usd

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.05

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.03

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.05

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.02

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

12835000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

12796000

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

12880000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

12834000

shares

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

240512000

usd

CY2021

us-gaap

Share Based Compensation

ShareBasedCompensation

1163000

usd

CY2021

swkh

Net Settlement For Employee Taxes On Restricted Stock And Options

NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions

-368000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

25929000

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

267236000

usd

CY2022

us-gaap

Share Based Compensation

ShareBasedCompensation

500000

usd

CY2022

swkh

Net Settlement For Employee Taxes On Restricted Stock And Options

NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions

-160000

usd

CY2022

us-gaap

Stock Repurchased During Period Value

StockRepurchasedDuringPeriodValue

1138000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

13491000

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

279929000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

13491000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

25929000

usd

CY2022

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

3491000

usd

CY2022

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

69000

usd

CY2021

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

49000

usd

CY2022

us-gaap

Deferred Income Taxes And Tax Credits

DeferredIncomeTaxesAndTaxCredits

-3941000

usd

CY2021

us-gaap

Deferred Income Taxes And Tax Credits

DeferredIncomeTaxesAndTaxCredits

6952000

usd

CY2022

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

-417000

usd

CY2021

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

-272000

usd

CY2022

us-gaap

Marketable Securities Unrealized Gain Loss

MarketableSecuritiesUnrealizedGainLoss

-528000

usd

CY2021

us-gaap

Marketable Securities Unrealized Gain Loss

MarketableSecuritiesUnrealizedGainLoss

1839000

usd

CY2022

swkh

Change In Fair Value Of Derivative Liability

ChangeInFairValueOfDerivativeLiability

754000

usd

CY2022

us-gaap

Marketable Securities Gain Loss

MarketableSecuritiesGainLoss

-151000

usd

CY2021

us-gaap

Marketable Securities Gain Loss

MarketableSecuritiesGainLoss

-140000

usd

CY2022

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

5170000

usd

CY2021

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

-287000

usd

CY2022

us-gaap

Amortization Of Deferred Loan Origination Fees Net

AmortizationOfDeferredLoanOriginationFeesNet

2204000

usd

CY2021

us-gaap

Amortization Of Deferred Loan Origination Fees Net

AmortizationOfDeferredLoanOriginationFeesNet

1130000

usd

CY2022

us-gaap

Paid In Kind Interest

PaidInKindInterest

5995000

usd

CY2021

us-gaap

Paid In Kind Interest

PaidInKindInterest

950000

usd

CY2022

us-gaap

Share Based Compensation

ShareBasedCompensation

500000

usd

CY2021

us-gaap

Share Based Compensation

ShareBasedCompensation

1163000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2599000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

4061000

usd

CY2022

us-gaap

Increase Decrease In Interest And Dividends Receivable

IncreaseDecreaseInInterestAndDividendsReceivable

-1291000

usd

CY2021

us-gaap

Increase Decrease In Interest And Dividends Receivable

IncreaseDecreaseInInterestAndDividendsReceivable

108000

usd

CY2022

swkh

Derivative Instrument Receivable

DerivativeInstrumentReceivable

-539000

usd

CY2022

us-gaap

Increase Decrease In Other Operating Assets

IncreaseDecreaseInOtherOperatingAssets

44000

usd

CY2021

us-gaap

Increase Decrease In Other Operating Assets

IncreaseDecreaseInOtherOperatingAssets

1788000

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

-1599000

usd

CY2021

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

2159000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

8202000

usd

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

34295000

usd

CY2022

us-gaap

Proceeds From Sale Of Equity Method Investments

ProceedsFromSaleOfEquityMethodInvestments

4151000

usd

CY2021

swkh

Cash Received From Settlement Of Warrants

CashReceivedFromSettlementOfWarrants

1875000

usd

CY2022

us-gaap

Payments To Acquire Finance Receivables

PaymentsToAcquireFinanceReceivables

93118000

usd

CY2021

us-gaap

Payments To Acquire Finance Receivables

PaymentsToAcquireFinanceReceivables

42350000

usd

CY2022

swkh

Proceeds Repayment Of Finance Receivables

ProceedsRepaymentOfFinanceReceivables

45673000

usd

CY2021

swkh

Proceeds Repayment Of Finance Receivables

ProceedsRepaymentOfFinanceReceivables

67192000

usd

CY2022

swkh

Marketable Investment Principal Payment

MarketableInvestmentPrincipalPayment

43000

usd

CY2021

swkh

Marketable Investment Principal Payment

MarketableInvestmentPrincipalPayment

122000

usd

CY2022

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

297000

usd

CY2021

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

1078000

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-43548000

usd

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

25761000

usd

CY2022

swkh

Net Settlement For Employee Taxes On Restricted Stock And Options

NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions

-160000

usd

CY2021

swkh

Net Settlement For Employee Taxes On Restricted Stock And Options

NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions

-368000

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

1138000

usd

CY2022

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

2437000

usd

CY2021

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

-11750000

usd

CY2022

us-gaap

Payment For Contingent Consideration Liability Financing Activities

PaymentForContingentConsiderationLiabilityFinancingActivities

2500000

usd

CY2021

us-gaap

Payment For Contingent Consideration Liability Financing Activities

PaymentForContingentConsiderationLiabilityFinancingActivities

8083000

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-1361000

usd

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-20201000

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-36707000

usd

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

39855000

usd

CY2021Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

42863000

usd

CY2020Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

3008000

usd

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

6156000

usd

CY2021Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

42863000

usd

CY2022

swkh

Warrants Received In Conjunction With Purchase Of Financial Receivables

WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables

1180000

usd

CY2021

swkh

Warrants Received In Conjunction With Purchase Of Financial Receivables

WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables

175000

usd

CY2022

us-gaap

Interest Paid Net

InterestPaidNet

268000

usd

CY2021

us-gaap

Interest Paid Net

InterestPaidNet

110000

usd

CY2021

swkh

Fair Value Of Common Stock Received In Connection With Payoff Of Term Loan

FairValueOfCommonStockReceivedInConnectionWithPayoffOfTermLoan

887000

usd

CY2022

swkh

Fair Value Of Common Stock Received Upon Exercise Of Warrant

FairValueOfCommonStockReceivedUponExerciseOfWarrant

3667000

usd

CY2022Q4

us-gaap

Inventory Raw Materials

InventoryRawMaterials

600000

usd

CY2021Q4

us-gaap

Inventory Raw Materials

InventoryRawMaterials

600000

usd

CY2022

us-gaap

Use Of Estimates

UseOfEstimates

Use of Estimates The preparation of the Company’s consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are required in the determination of revenue recognition; stock-based compensation; valuation of accounts receivable; impairment of finance receivables; long-lived assets; property and equipment; intangible assets; goodwill; valuation of warrants and other investments; contingent consideration; income taxes; and contingencies and litigation, among others. Some of these judgments can be subjective and complex, and consequently, actual results may differ from these estimates. The Company’s estimates often are based on complex judgments, probabilities and assumptions that it believes to be reasonable but that are inherently uncertain and unpredictable. For any given individual estimate or assumption made by the Company, there may also be other estimates or assumptions that are reasonable. The Company regularly evaluates its estimates and assumptions using historical experience and other factors, including the economic environment. As future events and their effects cannot be determined with precision, the Company’s estimates and assumptions may prove to be incomplete or inaccurate, or unanticipated events and circumstances may occur that might cause changes to those estimates and assumptions. Market conditions, such as illiquid credit markets, health crises such as the COVID-19 global pandemic, volatile equity markets, and economic downturns, can increase the uncertainty already inherent in the Company’s estimates and assumptions. The Company adjusts its estimates and assumptions when facts and circumstances indicate the need for change. Those changes generally will be reflected in our consolidated financial statements on a prospective basis unless they are required to be treated retrospectively under the relevant accounting standard. It is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.

CY2022

us-gaap

Number Of Operating Segments

NumberOfOperatingSegments

2

number

CY2022

swkh

Disclosure Swk Holdings Corporation And Summary Of Significant Accounting Policies Details Abstract

DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetailsAbstract_zqTPT6iPvHo6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SWK Holdings Corporation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 39%; font-weight: bold">Asset</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 39%; font-weight: bold; text-align: left">Estimated Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left">Lesser of lease term or useful life</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture, fixtures and equipment</td><td> </td> <td style="text-align: left"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxH_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z8GPNA1TwrXg" title="::XDX::P3Y">3 to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dxH_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zHfwr9FadjDg" title="::XDX::P15Y">15 years</td></tr> </table>

CY2022

us-gaap

Revenue Recognition Deferred Revenue

RevenueRecognitionDeferredRevenue

Deferred Revenue and Deferred Costs Deferred revenue includes amounts that have been billed per the contractual terms but have not been recognized as revenue. The Company classifies as current the portion of deferred revenue that is expected to be recognized within one year from the balance sheet date. Deferred revenue was $33,000 and $0.2 million as of December 31, 2022 and 2021, respectively, and is included in accounts payable and accrued liabilities in the consolidated balance sheets.

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

12796000

shares

CY2022

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

45000

shares

CY2021

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

38000

shares

CY2022

us-gaap

Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts

FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts

Allowance for Credit Losses on Finance Receivables The allowance for credit losses is intended to provide for credit losses inherent in the finance receivables portfolio and is periodically reviewed for adequacy considering credit quality indicators, including expected and historical losses and levels of and trends in past due loans, non-performing assets and impaired loans, collateral values and economic conditions. The allowance for credit losses is determined based on specific allowances for loans that are impaired, based upon the value of underlying collateral or projected cash flows. Changes to the allowance for credit losses are recorded in the provision for loan credit losses in the consolidated statements of income.

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

12880000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

12834000

shares

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.05

CY2022

us-gaap

Concentration Risk Credit Risk

ConcentrationRiskCreditRisk

Certain Risks and Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance receivables and marketable investments. The Company invests its excess cash with major U.S. banks and financial institutions. The Company has not experienced any losses on its cash and cash equivalents. Finance Receivables Segment The Company performs ongoing credit evaluations of its partner companies and generally requires collateral. For the year ended December 31, 2022, two of our business partners accounted for 31 percent of our interest and accounts receivable. For the year ended December 31, 2021, five of our business partners accounted for 63 percent of our interest and accounts receivable. Pharmaceutical Development Segment For the years ended December 31, 2022 and 2021, Cara accounted for approximately 87 percent and 98 percent, respectively, of Pharmaceutical Development segment revenues. The Company does not expect its current or future credit risk exposures to have a significant impact on its operations. However, there can be no assurance that its business will not experience any adverse impact from credit risk in the future.

CY2022

swkh

Disclosure Swk Holdings Corporation And Summary Of Significant Accounting Policies Details2 Abstract

DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureSWKHoldingsCorporationAndSummaryOfSignificantAccountingPoliciesDetails2Abstract_pn3n3_z5rbFwwCMBwh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SWK Holdings Corporation and Summary of Significant Accounting Policies (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20220101__20221231_zpb7cWme37x9" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49E_20210101__20211231_zQwNSsJX2qA8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ProfitLoss_zr1QHFN6jCj3" style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Net income</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">25,929</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pin3_zGoIVLXS7tth" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,835</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,796</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pin3_z0HKGcTLu5pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Effect of dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">38</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pin3_ztIYF6NaQ123" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Weighted-average diluted shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,880</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,834</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_pid_zMjdv5pJvsPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Basic net income per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EarningsPerShareDiluted_pid_zb7k9TyEYW27" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.65pt; padding-left: 8.65pt">Diluted net income per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.05</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

us-gaap

Profit Loss

ProfitLoss

13491000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

25929000

usd

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

12835000

shares

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.03

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.05

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.02

CY2022

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

248000

shares

CY2021

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

368000

shares

CY2022

swkh

Disclosure Goodwill And Intangible Assets Details Abstract

DisclosureGoodwillAndIntangibleAssetsDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureGoodwillAndIntangibleAssetsDetailsAbstract_pn3n3_zsxuJiJibrMg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; margin-bottom: 10pt" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_480_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zQ0Wa9aZrVhh" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_48C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zD3bJgDacXUc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_484_eus-gaap--IntangibleAssetsCurrent_iI_zs48BxRpwaN2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Net Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Estimated Useful Life</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_410_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zgh1zclf5Bb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">License Agreement(1)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">29,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">21,509</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">7,891</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_z7p5iSO7xCxl" style="width: 8%; text-align: right" title="::XDX::P10Y">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z1AUtzPHSo2i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Trade names and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">210</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z5xGdeGIGvSk" style="text-align: right" title="::XDX::P10Y">10</td><td style="text-align: left"> </td></tr> <tr id="xdx_417_20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zgqNe6HwGdpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Customer relationships</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">160</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220101__20221231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfWv7I7vp7Og" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P10Y">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_418_20221231_zRYoVEjUyR0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_480_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zbNAZvNlYdu5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_48C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zlGMWFJZq7q6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_484_eus-gaap--IntangibleAssetsCurrent_iI_zVWLMUO29IVk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Net Book Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Estimated Useful Life</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_41A_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zGSDTLCZv6H4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">License Agreement(1)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">29,400</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">19,780</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">9,620</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zoA0HCAeFn0c" style="width: 8%; text-align: right" title="::XDX::P10Y">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zu39LPIQHPnj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Trade names and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">210</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zALkzpCVJNbg" style="text-align: right" title="::XDX::P10Y">10</td><td style="text-align: left"> </td></tr> <tr id="xdx_417_20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zOp9ki876L2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Customer relationships</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">56</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">184</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zzk74S8oFfC5" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P10Y">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_410_20211231_z4ZKGtk4NA3d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,886</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,964</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 12pt; text-align: left">(1)</td><td style="text-align: justify">Prior to our acquisition of Enteris, Enteris entered into the License Agreement with Cara, for oral formulation rights to Enteris’ Peptelligence® technology to develop and commercialize Oral KORSUVATM in any indication worldwide, excluding South Korea and Japan. Cara is obligated to pay Enteris certain development, regulatory and tiered commercial milestone payments, as well as low single-digit royalties based on net sales in the licensed territory.</td> </tr></table> Amortization expense was $1.8 million and $3.5 million for the years ended December 31, 2022 and 2021, respectively, and was recorded in the consolidated statements of net income. Based on amounts recorded at December 31, 2022, the Company will recognize acquired intangible asset amortization as follows (in thousands): <p id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z0QmMqaUmZi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Schedule of Intangible Asset Amortization Expense

CY2022Q4

us-gaap

Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill

BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill

29850000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

21660000

usd

CY2022Q4

us-gaap

Intangible Assets Current

IntangibleAssetsCurrent

8190000

usd

CY2021Q4

us-gaap

Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill

BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill

29850000

usd

CY2021Q4

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

19886000

usd

CY2021Q4

us-gaap

Intangible Assets Current

IntangibleAssetsCurrent

9964000

usd

CY2022

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

1800000

usd

CY2021

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

3500000

usd

CY2022

swkh

Disclosure Goodwill And Intangible Assets Details2 Abstract

DisclosureGoodwillAndIntangibleAssetsDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureGoodwillAndIntangibleAssetsDetails2Abstract_pn3n3_zjVskG2RNl6f" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"/><td/> <td style="text-align: left"/><td id="xdx_49F_20221231_zhQP5FIhkk66" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzQY9_zFXwOzEFn7J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; text-align: left">2023</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,703</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzQY9_zBVYjP8bztW2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,546</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzQY9_zNbTdJtfRPkh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzQY9_znUGkDeT5fY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANzQY9_zpVyXwft0ET" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,076</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANzQY9_zsad9mIcsKa6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,713</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzQY9_zWMEgFQdSeRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

1703000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

1546000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

1076000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

1076000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

1076000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense After Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

1713000

usd

CY2022Q4

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

8190000

usd

CY2022Q4

us-gaap

Furniture And Fixtures Gross

FurnitureAndFixturesGross

59000

usd

CY2021Q4

us-gaap

Furniture And Fixtures Gross

FurnitureAndFixturesGross

38000

usd

CY2022Q4

us-gaap

Leasehold Improvements Gross

LeaseholdImprovementsGross

3656000

usd

CY2021Q4

us-gaap

Leasehold Improvements Gross

LeaseholdImprovementsGross

3648000

usd

CY2022

swkh

Disclosure Finance Receivables Details Abstract

DisclosureFinanceReceivablesDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureFinanceReceivablesDetailsAbstract_pn3n3_zt1IEALN7Gjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Finance Receivables (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49C_20221231_zJ8svBVyfIFb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49E_20211231_zbjC8vMapVK8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NotesReceivableGross_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceTermLoansMember_z3eoHSZVERt8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Term loans</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">188,836</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NotesReceivableGross_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceRoyaltyPurchasesMember_z4E8tGZPQg6h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Royalty purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">59,565</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesReceivableGross_iI_maNRNzInv_zQqV5GVJD42f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Total before allowance for credit losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">248,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">189,941</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iNI_di_msNRNzInv_zgAZANXaNO2b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Allowance for credit losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,846</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(8,388</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NotesReceivableNet_iTI_mtNRNzInv_zqWGlkzF6877" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Total carrying value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">236,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Notes Receivable Gross

NotesReceivableGross

248401000

usd

CY2021Q4

us-gaap

Notes Receivable Gross

NotesReceivableGross

189941000

usd

CY2022Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

11846000

usd

CY2021Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

8388000

usd

CY2022Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

236555000

usd

CY2021Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

181553000

usd

CY2022

swkh

Disclosure Finance Receivables Details2 Abstract

DisclosureFinanceReceivablesDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureFinanceReceivablesDetails2Abstract_pn3n3_zvGRaHcWPsVl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Finance Receivables (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_493_20221231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_zj9JdNrgCwLj" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20221231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--PerformingFinancingReceivableMember_zfFGKJRXY4Eb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49C_20221231_zuePmZ8lohn4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_492_20211231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_zebOYuJapcgc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_492_20211231__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--PerformingFinancingReceivableMember_z5LnWvwVezu6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49B_20211231_zOsBFiWzFfEf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Nonaccrual</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Performing</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Nonaccrual</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Performing</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_405_eus-gaap--NotesReceivableNet_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceTermLoansMember_zIE7WFLmZCeh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Term loans</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">11,304</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">177,532</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">188,836</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">18,288</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">118,024</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,312</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NotesReceivableNet_iI_hus-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--LifeScienceRoyaltyPurchasesMember_zicgC1AqsBVg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Royalty purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,736</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">40,983</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">47,719</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,362</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">41,879</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,241</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesReceivableNet_iI_zB7qztMLf9mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">Total carrying value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,040</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">218,515</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">236,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">159,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

236555000

usd

CY2021Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

181553000

usd

CY2022

swkh

Disclosure Property And Equipment Net Details Abstract

DisclosurePropertyAndEquipmentNetDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--DisclosurePropertyAndEquipmentNetDetailsAbstract_pn3n3_zdbaG44OmPn1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20221231_zUX5aNhX3Zu1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20211231_zuw8RLh7Anj8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentOther_iI_maPPAEGzBKP_zZTpZvwvr368" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Production equipment and other</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,895</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FurnitureAndFixturesGross_iI_maPPAEGzBKP_zzroXv0an7Kb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LeaseholdImprovementsGross_iI_maPPAEGzBKP_zuzdqUqGN4Tj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,648</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CapitalizedComputerSoftwareGross_iI_maPPAEGzBKP_z1pTI4UoFFg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Capitalized software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">87</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">84</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iTI_mtPPAEGzBKP_maPPAENzbIj_z8J1Mme4cSU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,697</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,812</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbIj_zZdQlv2YqyAa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,857</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,033</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbIj_zLXCZyDASc12" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,840</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,779</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Property Plant And Equipment Other

PropertyPlantAndEquipmentOther

3895000

usd

CY2021Q4

us-gaap

Property Plant And Equipment Other

PropertyPlantAndEquipmentOther

3042000

usd

CY2022Q4

us-gaap

Capitalized Computer Software Gross

CapitalizedComputerSoftwareGross

87000

usd

CY2021Q4

us-gaap

Capitalized Computer Software Gross

CapitalizedComputerSoftwareGross

84000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

7697000

usd

CY2021Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

6812000

usd

CY2022Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1857000

usd

CY2021Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1033000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

5840000

usd

CY2021Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

5779000

usd

CY2022

swkh

Disclosure Marketable Investments Details Abstract

DisclosureMarketableInvestmentsDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureMarketableInvestmentsDetailsAbstract_pn3n3_zd0KPodjOYZf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_499_20221231_zxdEgvXpuylk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49F_20211231_zdN5shFp05u5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AvailableForSaleSecuritiesDebtSecurities_iI_maIzegN_zKQnm1NRipAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Corporate debt securities</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">119</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MarketableSecurities_iI_maIzegN_zRoEpU1rXEq4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Equity securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,034</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Investments_iTI_mtIzegN_zaN5aJhHICW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total marketable investments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,153</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

76000

usd

CY2021Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

119000

usd

CY2021Q4

us-gaap

Marketable Securities

MarketableSecurities

1034000

usd

CY2022Q4

us-gaap

Investments

76000

usd

CY2021Q4

us-gaap

Investments

1153000

usd

CY2022

swkh

Disclosure Marketable Investments Details2 Abstract

DisclosureMarketableInvestmentsDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureMarketableInvestmentsDetails2Abstract_pn3n3_zuTRgxo1KBag" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Amortized Cost</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Unrealized Gains</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross Unrealized Losses</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2022</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zaxmlAK9Hkkk" style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zV6a7JKgMXrd" style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zz5GakUq3ZG1" style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AvailableForSaleSecurities_iI_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zmAkQa3xSN64" style="width: 8%; text-align: right">76</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleDebtSecuritiesAmortizedCostBasis_iI_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zSoAzFDQvf7i" style="text-align: right">119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zI1gGuSsJiei" style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_c20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_z1Muzy8WZIFi" style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecurities_iI_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CorporateDebtSecuritiesMember_zHLX646asxQ8" style="text-align: right">119</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Marketable Investments Details3 Abstract

DisclosureMarketableInvestmentsDetails3Abstract

<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureMarketableInvestmentsDetails3Abstract_pn3n3_zM0Wu76HhGF4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Marketable Investments (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_498_20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zVSLCsr5JEkk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49A_20210101__20211231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zUFmsUS4JBb3" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_z42jp1xjUUL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Unrealized net (loss) gain on equity securities reflected in the Consolidated Statements of Income</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(528</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,839</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfCommonStockReceivedUponExerciseOfWarrant_zW6xKOWQdqE4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Fair value of common stock received upon exercise of warrant to purchase stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--CashReceivedFromSettlementOfWarrants_zVbLRU47Yh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Proceeds received on sale/tender of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,875</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--MarketableSecuritiesGainLoss_zOQAbGedznti" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Realized net loss on sale/tender of equity securities reflected in the Consolidated Statements of Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(151</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(140</td><td style="text-align: left">)</td></tr> </table>

CY2022Q4

us-gaap

Line Of Credit Facility Fair Value Of Amount Outstanding

LineOfCreditFacilityFairValueOfAmountOutstanding

2400000

usd

CY2022Q4

us-gaap

Line Of Credit Facility Remaining Borrowing Capacity

LineOfCreditFacilityRemainingBorrowingCapacity

32600000

usd

CY2022

swkh

Disclosure Commitments And Contingencies Details Abstract

DisclosureCommitmentsAndContingenciesDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureCommitmentsAndContingenciesDetailsAbstract_pn3n3_zpU8FXZFppGi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"/><td/> <td style="text-align: left"/><td id="xdx_490_20221231_zzAedsHjg849" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzbLh_zLWry4gWXXzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2023</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">335</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzbLh_z0yCi6YHWdod" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">336</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzbLh_zY5ZnWnT9Tdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzbLh_zlB5UuO9emB9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzbLh_zrNspe3ml2Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzbLh_zzkPZN6uWoyd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-align: left; text-indent: -8.65pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">549</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzbLh_zt4cpzHqKkg3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total future lease payments</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,099</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

335000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

336000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

325000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

277000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

277000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due After Year Five

LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

549000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

2099000

usd

CY2021Q4

us-gaap

Other Assets Fair Value Disclosure

OtherAssetsFairValueDisclosure

3419000

usd

CY2021Q4

swkh

Contingent Consideration Payable At Fair Value

ContingentConsiderationPayableAtFairValue

8530000

usd

CY2021Q4

swkh

Contingent Consideration Payable

ContingentConsiderationPayable

8530000

usd

CY2022

swkh

Disclosure Commitments And Contingencies Details2 Abstract

DisclosureCommitmentsAndContingenciesDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureCommitmentsAndContingenciesDetails2Abstract_pn3n6_z53fljfS5eLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt"/><td/> <td style="text-align: left"/><td id="xdx_485_eus-gaap--CommitmentsAndContingencies_iI_pn3n6_zVb4rGJD84i7" style="text-align: right"/><td style="text-align: left"/></tr> <tr id="xdx_41E_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ExeevoIncMember_zKvxgda1jkS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Exeevo, Inc.</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2.5</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_419_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MedMinderSystemsIncMember_zPeuxVFfxuc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">MedMinder Systems, Inc.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.0</td><td style="text-align: left"> </td></tr> <tr id="xdx_419_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DuoRoyaltyMember_znI43rpc5QAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Duo Royalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.4</td><td style="text-align: left"> </td></tr> <tr id="xdx_41A_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SincerusPharmaceuticalsIncMember_zsX61P64P8w8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Sincerus Pharmaceuticals, Inc.</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2.0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_41A_20221231__us-gaap--FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis__us-gaap--UnfundedLoanCommitmentMember_zD5USy1GWoV7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total unfunded commitments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11.9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

250000000

shares

CY2022Q2

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

10000000.0

usd

CY2022

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

63901

shares

CY2022

swkh

Disclosure Stockholders Equity Details Abstract

DisclosureStockholdersEquityDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--DisclosureStockholdersEquityDetailsAbstract_pp0p0_zCyv6jvkabsi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number of Shares</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted- Average Exercise Price</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-Average Remaining Contractual Term (in years)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Aggregate Intrinsic Value (in thousands)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2020</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVkIjHrUVoM2" style="width: 8%; text-align: right">362,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3c3QbpjliRe" style="width: 8%; text-align: right">12.47</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zshs1LJRrIWd" style="width: 8%; text-align: right" title="::XDX::P5Y7M6D">5.6</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0n3_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zW4P4u6t3sJ6" style="width: 8%; text-align: right">810.1</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options canceled and retired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkjxaQRqDNs6" style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDmKKkgoMpsh" style="text-align: right">(75,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zDccnebvD5m4" style="text-align: right">8.30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Options granted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlVeVpuUczn1" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zU9S3ngfS9dl" style="text-align: right">287,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za7VU7uE5b4c" style="text-align: right">10.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zlKYbtq5IHuh" style="text-align: right" title="::XDX::P5Y8M12D">5.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0n3_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZGuO6ned5ei" style="text-align: right">1745.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options canceled and retired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zt7l0vpbUnZa" style="text-align: right">(72,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zEj8ZXezlVc3" style="text-align: right">14.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVxNlwszPOmi" style="text-align: right">(125,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTNplNmismjd" style="text-align: right">12.98</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Options granted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z45VifDwBEa6" style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balances, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zx3WJlOFVFqj" style="border-bottom: Black 2.5pt double; text-align: right">90,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwRfoRanQga1" style="padding-bottom: 2.5pt; text-align: right">10.88</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zhX5i86I0xTl" style="padding-bottom: 2.5pt; text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0n3_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVHQKNehgCR6" style="padding-bottom: 2.5pt; text-align: right">363.8</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Options vested and exercisable and expected to be vested and exercisable at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zcmd9fwMuL9k" style="text-align: right">90,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_za5wq1wOmQFa" style="text-align: right">10.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVmQdxaUe1zi" style="text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0n3_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqUIrq4xRQrl" style="text-align: right">363.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Options vested and exercisable at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvAdD4fF6Px" style="text-align: right">82,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zKwyDpYLIFWf" style="text-align: right">13.35</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z12gak5G2amk" style="text-align: right" title="::XDX::P6Y3M18D">6.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0n3_c20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zarezMQXTCe2" style="text-align: right">353.7</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Stockholders Equity Details2 Abstract

DisclosureStockholdersEquityDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureStockholdersEquityDetails2Abstract_pid_zh6tYX6N5AYa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Stockholders' Equity (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Exercise Prices</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_484_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_zjVsK018QVdd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number Outstanding</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted-Average Remaining Contractual Life (in years)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_486_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_zYgUQVEgyHMa" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted- Average Exercise Price per Share</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_481_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_zgBKJRwQfkPc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number Exercisable</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_480_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_z556Y2AvTgzl" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted- Average Exercise Price per Share</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_412_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.61Member_zYjUtxnWhls5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">9.61</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.61Member_z3oXFie4HJEe" style="width: 13%; text-align: right" title="::XDX::P0Y">3.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9.61</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9.61</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_41D_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50Member_zAtXg2Da7g94" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">12.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxHU_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50Member_ztTEDtHlLwdd" style="text-align: right" title="::XDX::P0Y">6.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td></tr> <tr id="xdx_410_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50TwoMember_zWn21S0JuSTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">12.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxHU_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice12.50TwoMember_z1fOS3Ybbp9e" style="text-align: right" title="::XDX::P0Y">6.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.50</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29Member_z0i8UnOXjAMb" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29Member_z716Idot1FTg" style="text-align: right" title="::XDX::P0Y">7.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29TwoMember_zl4323qygeD" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29TwoMember_zwzMVEgx3XLg" style="text-align: right" title="::XDX::P0Y">7.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.29</td><td style="text-align: left"> </td></tr> <tr id="xdx_41E_20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29ThreeMember_zQA7y92LYa1b" style="vertical-align: bottom; background-color: White"> <td> </td> <td style="text-align: right; padding-left: 8.65pt; text-indent: -8.65pt">16.29</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dxH_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice16.29ThreeMember_zwpils8MthQk" style="border-bottom: Black 1pt solid; text-align: right" title="::XDX::P0Y">7.5</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16.29</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16.29</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_410_20221231_zCdZk3BinOEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="padding-left: 8.65pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">90,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10.88</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">82,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13.35</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

90000

shares

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

10.88

CY2022Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

82500

shares

CY2022Q4

us-gaap

Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1

SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

13.35

CY2022

swkh

Disclosure Fair Value Measurements Details Abstract

DisclosureFairValueMeasurementsDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureFairValueMeasurementsDetailsAbstract_pn3n3_zCtNjup7cPxk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztB4SbiPksbe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying Value in Consolidated Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqMxfOx5jMPe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSnlMjZ2unKf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgJPJTuT2d9e" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Unobservable Inputs (Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_ecustom--FinancialAssetsAbstract_iB_zBWnTRuTUilf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--WarrantAssets_i01I_pn3n3_z2llb6lxIJQk" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,220</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InvestmentsFairValueDisclosure_i01I_pn3n3_zOy9vpdXWse6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--FinancialLiabilitiesAbstract_iB_zZNWr2vofZwb" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--ContingentConsiderationPayable_i01I_pn3n3_z5luIMp6qtMh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DerivativeLiabilities_i01I_pn3n3_zIMseKoQO1hk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Derivative liability - foreign currency forward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td></tr> </table> The following table presents financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 (in thousands): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzM1bxPLiWu9" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying Value in Consolidated Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zEhhC0CULux6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRHzf8RULGj8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGkZ1478Ag5i" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Unobservable Inputs (Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--FinancialAssetsAbstract_iB_zraJcVtpCUUe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--WarrantAssets_i01I_pn3n3_zrrDHF3L2yXc" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,419</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,419</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InvestmentsFairValueDisclosure_i01I_pn3n3_zuiOsTPX9O5j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--FinancialLiabilitiesAbstract_iB_zwHJUFK4fqBg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ContingentConsiderationPayable_i01I_pn3n3_zGiyoeUIRwEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Fair Value Measurements Details2 Abstract

DisclosureFairValueMeasurementsDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureFairValueMeasurementsDetails2Abstract_pn3n3_zYks6e9Z4nEl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Fair Value Measurements (Details 2)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B9_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsRecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_zUZMheTE7bel" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_438_c20210101__20211231_ecustom--WarrantAssets_iS_pn3n3_ztQxuwewFMq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2020</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--WarrantIssuances_pn3n3_zEZkRiVDGo4c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175</td><td style="text-align: left"> </td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--WarrantsCanceled_pn3n3_zuIimkJglXhj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_433_c20210101__20211231_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_zyKlDROCbPt3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">272</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--WarrantAssets_iE_pn3n3_zAiqhKzxi732" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_430_c20220101__20221231_ecustom--WarrantIssuances_pn3n3_zoEU1lED9jEi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,180</td><td style="text-align: left"> </td></tr> <tr id="xdx_43D_c20220101__20221231_ecustom--WarrantExercised_pn3n3_zVMs6gS7i9F1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,796</td><td style="text-align: left">)</td></tr> <tr id="xdx_437_c20220101__20221231_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_znXvQ4pBtWi9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">417</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43A_c20220101__20221231_ecustom--WarrantAssets_iE_pn3n3_zMzdZ6UcE0o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Fair Value - December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,220</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Fair Value Measurements Details3 Abstract

DisclosureFairValueMeasurementsDetails3Abstract

<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DisclosureFairValueMeasurementsDetails3Abstract_zQ9ioEW7BCD" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - Fair Value Measurements (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Dividend rate</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 8%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp0_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zRVwXmWpLzj5">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 8%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp0_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember_zqnHi9CTZcjj">—</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zby83oDEDuzb">4.0% to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zg8pxcxsMcNd">4.3%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zhd0FtNEBgJl">0.97% to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zyVyk38nYcO9">1.44%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Expected life (years)</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"> <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z2dMb9IZ52gc" title="::XDX::P2Y">2.0 to <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_z1fRPYHHBpEe" title="::XDX::P6Y10M24D">6.9 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_ztfivnXJUZn6" title="::XDX::P2Y7M6D">2.6 to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zKRiP9POL8m2" title="::XDX::P7Y">7.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"> <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zp7kKzjG9jWd">54.8% to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zPFaFOOtDrMl">139.4% </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zC5Fzp1eAukc">60.2% to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zn23os7lcVK">142.0%</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Fair Value Measurements Details4 Abstract

DisclosureFairValueMeasurementsDetails4Abstract

<table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureFairValueMeasurementsDetails4Abstract_pn3n3_zwQB0veJcBfd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 4)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4BD_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_zCqQrbTpYzoe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total Carrying Value in Consolidated Balance Sheets</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4B7_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel1Member_zI62mQ7PqFbi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4B7_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel2Member_zqFiwtDIgLg8" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_4BE_us-gaap--FairValueByMeasurementFrequencyAxis_us-gaap--FairValueMeasurementsNonrecurringMember_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_zQohLh2AmH6d" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Significant Unobservable Inputs (Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_43F_c20221231_eus-gaap--InvestmentsFairValueDisclosure_iI_z1XzxA4k4Wfh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2022</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,545</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,545</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43D_c20211231_eus-gaap--InvestmentsFairValueDisclosure_iI_z7G4zoVzTcHf" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-left: 8.65pt; text-indent: -8.65pt">December 31, 2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,612</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Fair Value Measurements Details5 Abstract

DisclosureFairValueMeasurementsDetails5Abstract

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureFairValueMeasurementsDetails5Abstract_pn3n3_zcLtqQQ4f0e7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 5)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Carrying Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20221231_zPeuca5YNePf" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpgiSWUck4ib" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 1</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCwEb6NpuQH7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 2</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmbMofVqAFn1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 3</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_ecustom--FinancialAssetsAbstract0_iB_ztnjhBICpGie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LoansReceivableFairValueDisclosure_i01I_zoygMvg21XAc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance receivables</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesReceivableNet_i01I_c20221231_z4wR2g1Zb6tg" style="text-align: right">236,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">236,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">236,555</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zwJdR8AULtO2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Investments_i01I_c20221231_zBPKeSeF5uOa" style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAssetsFairValueDisclosure_i01I_zBt0Y10yTpEe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OtherAssets_i01I_c20221231_zQDwAtZ3Rtfd" style="text-align: right">1,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,220</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--FinancialLiabilitiesAbstract_iB_ziBTEYii9bMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ContingentConsiderationPayable_i01I_zErcvILvcvH5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ContingentConsiderationPayableAtFairValue_i01I_c20221231_zm7RMeyYcBT9" style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Derivative liability - foreign currency forward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">754</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td style="text-align: left"> </td><td style="text-align: left"> </td><td style="text-align: right">754</td></tr> </table> For the year ended December 31, 2021 (in thousands): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Carrying Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20211231_zkwJR7IEJ717" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Fair Value</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zh0lKWSO04D4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 1</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIvEndzdbx1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 2</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z71KZbqVsdza" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Level 3</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_ecustom--FinancialAssetsAbstract0_iB_zPXCIT1QU04d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LoansReceivableFairValueDisclosure_i01I_z09Xj8E4FmLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Finance receivables</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesReceivableNet_i01I_c20211231_zobrWlukULbl" style="text-align: right">181,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">181,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">181,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InvestmentsFairValueDisclosure_i01I_zJMLdYzRDMC2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Marketable investments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Investments_i01I_c20211231_zc0fHyiYatgj" style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAssetsFairValueDisclosure_i01I_zIYt84KKLFU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Warrant assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherAssets_i01I_c20211231_zGMWjcBUpIG2" style="text-align: right">3,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,419</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-indent: -8.65pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FinancialLiabilitiesAbstract_iB_zmE60YGKClJj" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Financial liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ContingentConsiderationPayable_i01I_zRF4eKRzdVz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration payable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--ContingentConsiderationPayableAtFairValue_i01I_c20211231_zjvk2kHjRZP" style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,530</td><td style="text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

236555000

usd

CY2022Q4

us-gaap

Loans Receivable Fair Value Disclosure

LoansReceivableFairValueDisclosure

236555000

usd

CY2022Q4

us-gaap

Investments

76000

usd

CY2022Q4

us-gaap

Investments Fair Value Disclosure

InvestmentsFairValueDisclosure

76000

usd

CY2022Q4

us-gaap

Other Assets

OtherAssets

1220000

usd

CY2022Q4

us-gaap

Other Assets Fair Value Disclosure

OtherAssetsFairValueDisclosure

1220000

usd

CY2022Q4

swkh

Contingent Consideration Payable At Fair Value

ContingentConsiderationPayableAtFairValue

11200000

usd

CY2022Q4

swkh

Contingent Consideration Payable

ContingentConsiderationPayable

11200000

usd

CY2021Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

181553000

usd

CY2021Q4

us-gaap

Loans Receivable Fair Value Disclosure

LoansReceivableFairValueDisclosure

181553000

usd

CY2021Q4

us-gaap

Investments

1153000

usd

CY2021Q4

us-gaap

Investments Fair Value Disclosure

InvestmentsFairValueDisclosure

1153000

usd

CY2021Q4

us-gaap

Other Assets

OtherAssets

3419000

usd

CY2022

swkh

Disclosure Revenue Recognition Details Abstract

DisclosureRevenueRecognitionDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--DisclosureRevenueRecognitionDetailsAbstract_pn3n3_z4wYh4pf8Em7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Revenue Recognition (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20220101__20221231_z0Um12tAl6i4" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_496_20210101__20211231_zeG83YRptDqi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical Development Segment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_zzo12CevErz1" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">License Agreement</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">5,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">15,871</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zGUFJn8hQm0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical development and other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">753</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">974</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zi6LwJMpFCCb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total contract revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,008</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

swkh

Disclosure Revenue Recognition Details2 Abstract

DisclosureRevenueRecognitionDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureRevenueRecognitionDetails2Abstract_pn3n3_zxceV6hTLrqh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Revenue Recognition (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20221231_zVS4TD8XBGNg" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_497_20211231_z2Vh0e6xWQob" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Pharmaceutical Development Segment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredRevenue_iI_z2mjdkzRgQEi" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred revenue</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">33</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">185</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iI_zIqYUoofewch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total contract liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">33</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Deferred Revenue

DeferredRevenue

33000

usd

CY2021Q4

us-gaap

Deferred Revenue

DeferredRevenue

185000

usd

CY2022Q4

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

33000

usd

CY2021Q4

us-gaap

Contract With Customer Liability

ContractWithCustomerLiability

185000

usd

CY2022

swkh

Disclosure Segment Information Details Abstract

DisclosureSegmentInformationDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureSegmentInformationDetailsAbstract_pn3n3_znSCiOWDpFJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Year Ended December 31, 2022</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--FinanceReceivablesMember_zIEfp8G0YJve" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Finance Receivables</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zbnBurbzNDMk" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Pharmaceutical Development and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--HoldingCompanyAndOtherMember_zDL3mUipRoAb" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Holding Company and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231_z8sRNDCo3vm" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_ecustom--RevenuesExcludingOtherRevenue_zPkGUsSV2Et7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">35,461</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">5,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">40,946</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueNotFromContractWithCustomerOther_zmdJFgAozWw4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">538</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ProvisionForLoanAndLeaseLosses_zCBwwjv6drG3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Provision for credit losses and impairment expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,491</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InterestExpense_z4y5UTz2CNwl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">340</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ResearchAndDevelopmentExpense_zWOLkpVCb6gh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Manufacturing, research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,952</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,952</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ChangeInFairValueOfAcquisitionrelatedContingentConsideration_zSl0HCCp0HGl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value of contingent consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,170</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DepreciationAndAmortization_zQjwdXljuG38" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Depreciation and amortization expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,593</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--GeneralAndAdministrativeExpense_z90gZphw2PRk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">333</td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,964</td><td style="text-align: left"/></tr> <tr id="xdx_406_eus-gaap--OtherOperatingIncomeExpenseNet_zHtJ894SL1Fg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(477</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(477</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ProfitLoss_znvlvsUklUm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Consolidated net income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,829</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,324</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,014</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,491</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Year Ended December 31, 2021</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--FinanceReceivablesMember_zMpOv2d7ZeTi" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Finance Receivables</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--PharmaceuticalDevelopmentServicesMember_zlB7qU3VFIJe" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Pharmaceutical Development and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--HoldingCompanyAndOtherMember_zw2T9BHODmGc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Holding Company and Other</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210101__20211231_z8p3qvInHlhd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenuesExcludingOtherRevenue_zSoVSvPgON11" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; padding-left: 8.65pt; text-indent: -8.65pt">Revenue</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">39,310</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">16,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">55,432</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomerOther_zECjCl5rGuPg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">723</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">723</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestExpense_zchkFg520oGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ResearchAndDevelopmentExpense_z7k6yiZN07U3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Manufacturing, research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,347</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DepreciationAndAmortization_zcEjd7VsEU2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Depreciation and amortization expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,061</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ChangeInFairValueOfAcquisitionrelatedContingentConsideration_zZzhUO3JT31k" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in fair value of acquisition-related contingent consideration</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(287</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(287</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_zdkjzSyVPg24" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,983</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,824</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,620</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherOperatingIncomeExpenseNet_zf05rUNBZtR8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Other income, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,971</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_zvHoCxSENMA2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Income tax expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,082</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,082</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProfitLoss_zz4lnSa94Rtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Consolidated net income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,747</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,912</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,929</td><td style="text-align: left"> </td></tr> </table>

CY2022

swkh

Revenues Excluding Other Revenue

RevenuesExcludingOtherRevenue

40946000

usd

CY2022

us-gaap

Revenue Not From Contract With Customer Other

RevenueNotFromContractWithCustomerOther

538000

usd

CY2022

us-gaap

Provision For Loan And Lease Losses

ProvisionForLoanAndLeaseLosses

3491000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

340000

usd

CY2022

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

6952000

usd

CY2022

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

5170000

usd

CY2022

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

2599000

usd

CY2022

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

12964000

usd

CY2022

us-gaap

Other Operating Income Expense Net

OtherOperatingIncomeExpenseNet

-477000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

13491000

usd

CY2021

swkh

Revenues Excluding Other Revenue

RevenuesExcludingOtherRevenue

55432000

usd

CY2021

us-gaap

Revenue Not From Contract With Customer Other

RevenueNotFromContractWithCustomerOther

723000

usd

CY2021

us-gaap

Interest Expense

InterestExpense

374000

usd

CY2021

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

7347000

usd

CY2021

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

4061000

usd

CY2021

swkh

Change In Fair Value Of Acquisitionrelated Contingent Consideration

ChangeInFairValueOfAcquisitionrelatedContingentConsideration

-287000

usd

CY2021

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

13620000

usd

CY2021

us-gaap

Other Operating Income Expense Net

OtherOperatingIncomeExpenseNet

1971000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

7082000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

25929000

usd

CY2022

swkh

Disclosure Income Taxes Details Abstract

DisclosureIncomeTaxesDetailsAbstract

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureIncomeTaxesDetailsAbstract_pn3n3_zEfWp2Udm1Kc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_498_20220101__20221231_z00BHFah80g7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49D_20210101__20211231_z72QzFO36Lyh" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--CurrentFederalTaxExpenseBenefit_zzUE9GJIJkKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-left: 8.65pt; text-indent: -8.65pt">U.S.</td><td style="width: 3%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 8%; text-align: right">9,491 </td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 8%; text-align: right">33,011</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

9491000

usd

CY2021

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

33011000

usd

CY2022

swkh

Disclosure Income Taxes Details2 Abstract

DisclosureIncomeTaxesDetails2Abstract

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureIncomeTaxesDetails2Abstract_pn3n3_zKlophLcNqEi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20220101__20221231_zl2DXy1jhbqd" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_494_20210101__20211231_za6HusxVFkF6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zfGQxdA0kgth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Current (benefit) expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_maITEBzrLC_zM4zhunXAs5a" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; padding-left: 17.3pt; text-indent: -8.65pt">State</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(59</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">185</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zjuG229z78oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred (benefit) expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_maITEBzrLC_zybTNOMCVHCa" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Federal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,922</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,944</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_maITEBzrLC_zMQkUrQJufvk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; padding-left: 17.3pt">State</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(19</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(47</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_i01T_mtITEBzrLC_zHhTBvMgRGl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 25.95pt">Total income tax (benefit) expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

-59000

usd

CY2021

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

185000

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-3922000

usd

CY2021

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

6944000

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-19000

usd

CY2021

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-47000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-4000000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

7082000

usd

CY2022

swkh

Disclosure Income Taxes Details3 Abstract

DisclosureIncomeTaxesDetails3Abstract

<table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureIncomeTaxesDetails3Abstract_pn3n3_z5CQgY5rLLj3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_499_20220101__20221231_zt5UpL9L4yM1" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20210101__20211231_zZg4IJwyDFzc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCzIX3_ziJ1asdl3GE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Federal tax provision at statutory rate</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,035</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">6,945</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCzIX3_zlEle9KXzqr6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,587</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21,208</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maCzIX3_zqnVNQiUeDi7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">State taxes, net of federal income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(97</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Mark-to-market adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(88</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(58</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments_maCzIX3_zUtX1ya7zsug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Tax credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"/></tr> <tr id="xdx_40A_ecustom--EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation_maCzIX3_zzcnuSgeWs38" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Contingent consideration revaluation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_maCzIX3_zJ12m8tb1fba" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(125</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets_maCzIX3_zVci3RElVtn1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Write off of deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,905</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,493</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_mtCzIX3_zElrtoNnjFik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Total income tax (benefit) expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2022

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

2035000

usd

CY2021

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

6945000

usd

CY2022

us-gaap

Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance

IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

-9587000

usd

CY2021

us-gaap

Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance

IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

-21208000

usd

CY2022

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

-97000

usd

CY2021

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

95000

usd

CY2022

swkh

Effective Income Tax Rate Reconciliation Mark To Market Adjustments

EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments

-403000

usd

CY2022

swkh

Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation

EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation

1044000

usd

CY2021

swkh

Effective Income Tax Rate Reconciliation Contingent Consideration Revaluation

EffectiveIncomeTaxRateReconciliationContingentConsiderationRevaluation

-60000

usd

CY2022

us-gaap

Income Tax Reconciliation Other Reconciling Items

IncomeTaxReconciliationOtherReconcilingItems

191000

usd

CY2021

us-gaap

Income Tax Reconciliation Other Reconciling Items

IncomeTaxReconciliationOtherReconcilingItems

-125000

usd

CY2022

swkh

Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets

EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets

2905000

usd

CY2021

swkh

Effective Income Tax Rate Reconciliation Write Off Of Deferred Tax Assets

EffectiveIncomeTaxRateReconciliationWriteOffOfDeferredTaxAssets

21493000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-4000000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

7082000

usd

CY2022

swkh

Disclosure Income Taxes Details4 Abstract

DisclosureIncomeTaxesDetails4Abstract

<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureIncomeTaxesDetails4Abstract_pn3n3_zcd3PgBwVvyh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Income Taxes (Details 4)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"/><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_495_20221231_zgx8USZSWOpc" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/> <td id="xdx_49D_20211231_zPzB4e4sW8Bl" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center"/><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center; padding-left: 8.65pt; text-indent: -8.65pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB_z49qqf2uWNAj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_maCz7ni_zUcr2S79c0yf" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Credit carryforward</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,947</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,077</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_maCz7ni_zeXZud1Kh1Ak" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_maCz7ni_zctnTA2yJ9ki" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,846</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,334</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_maCz7ni_ztFhnlkCa8Eg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Net operating losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26,158</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">32,362</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_mtCz7ni_maCzIIP_z6ZcS9ZX6gOd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,094</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zadp1BSkJx3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_di_msCzIIP_zMtpUwMrqQI2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 17.3pt; text-indent: -8.65pt">Intangible assets other than goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,288</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,609</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesOther_i01I_msCzIIP_z9QadwIRHXI9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 17.3pt; text-indent: -8.65pt">Other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(629</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(479</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msCzIIP_zjrxQck3PUmi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 8.65pt; text-indent: -8.65pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,697</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,284</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtCzIIP_zaAUhILpHrre" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Net deferred tax assets</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,480</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">20,539</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

CY2022Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

2947000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

3077000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

143000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

138000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

3846000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

3334000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

26158000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

32362000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

33094000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

38911000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

1288000

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

1609000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

-629000

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

-479000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

6697000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

16284000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

24480000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

20539000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

124500000

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

600000

usd

CY2021Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

300000

usd

Name	View Source	Status
0001552781-23-000219-index-headers.html	Edgar Link	pending
0001552781-23-000219-index.html	Edgar Link	pending
0001552781-23-000219.txt	Edgar Link	pending
0001552781-23-000219-xbrl.zip	Edgar Link	pending
e23137001.jpg	Edgar Link	pending
e23137_ex10-11.htm	Edgar Link	pending
e23137_ex10-8.htm	Edgar Link	pending
e23137_ex21-1.htm	Edgar Link	pending
e23137_ex23-1.htm	Edgar Link	pending
e23137_ex31-1.htm	Edgar Link	pending
e23137_ex31-2.htm	Edgar Link	pending
e23137_ex32-1.htm	Edgar Link	pending
e23137_ex32-2.htm	Edgar Link	pending
e23137_ex4-2.htm	Edgar Link	pending
e23137_swkh-10k.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
e23137_swkh-10k_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
swkh-20221231.xsd	Edgar Link	pending
swkh-20221231_def.xml	Edgar Link	unprocessable
swkh-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
swkh-20221231_cal.xml	Edgar Link	unprocessable
swkh-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWKH
SWK Holdings Corp Stock $swkh

2023 Q1 Form 10-K Financial Statement

#000155278123000219 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWKH SWK Holdings Corp Stock $swkh

2023 Q1 Form 10-K Financial Statement

#000155278123000219 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWKH
SWK Holdings Corp Stock $swkh